Nasal OEC transplantation	1
respiratory recovery	36
a subchronic rat model of cervical spinal cord contusion J.C. Stamegna a	60
a subchronic rat model	60
cervical spinal cord contusion J.C. Stamegna a	86
cervical spinal cord contusion J.C. Stamegna	86
a	132
b ,1 , M.S Felix a , b ,1 , J. Roux-Peyronnet a , b , V. Rossi a , b , F. Féron c , d , P. Gauthier a , b , V. Matarazzo a , b , a Centre de Recherche en Neurobiologie et Neurophysiologie de Marseille , CRN2M , CNRS UMR6231 , 13397 Marseille , France b Université Paul Cézanne , 13397 Marseille , France c Neurobiologie des Interactions Cellulaires et Neurophysiopathologie , NICN , CNRS UMR 6184 , Université de la Méditerranée , 13344 Marseille , France d Centre d'Investigations Cliniques en Biothérapie CIC-B 510 , AP-HM , Institut Paoli Calmettes , Inserm , Université de la Méditerranée ,	134
b ,1	134
M.S Felix a	139
M.S Felix	139
a	149
b ,1	151
J. Roux-Peyronnet a	156
J. Roux-Peyronnet	156
a	174
b	176
V. Rossi a	179
V. Rossi	179
a	188
b	190
F. Féron c	193
F. Féron	193
c	202
d	204
P. Gauthier a	207
P. Gauthier	207
a	219
b	221
V. Matarazzo a	224
V. Matarazzo	224
a	237
b	239
a Centre de Recherche en Neurobiologie et Neurophysiologie de Marseille , CRN2M	243
a Centre de Recherche	243
Neurobiologie et Neurophysiologie de Marseille , CRN2M	268
CNRS UMR6231	323
13397 Marseille	337
13397	337
Marseille	343
France b Université Paul Cézanne	354
13397 Marseille	388
France c Neurobiologie des Interactions Cellulaires et Neurophysiopathologie	405
France c Neurobiologie des	405
Interactions	432
Cellulaires et Neurophysiopathologie	445
NICN , CNRS UMR 6184	483
Université de la Méditerranée	504
13344 Marseille	535
France d Centre d'Investigations Cliniques en Biothérapie CIC-B 510 , AP-HM	552
France d Centre d'Investigations Cliniques	552
Biothérapie CIC-B 510 , AP-HM	598
Biothérapie CIC-B 510	598
AP-HM	621
Institut Paoli Calmettes	628
Inserm , Université de la Méditerranée	654
Marseille	693
France ABSTRACT Engraftment of nasal olfactory ensheathing cells -LRB- OEC -RRB-	704
France ABSTRACT Engraftment	704
nasal olfactory ensheathing cells -LRB- OEC -RRB-	736
nasal olfactory ensheathing cells	736
OEC	771
a promising therapeutic strategy for spinal cord repair	793
a promising therapeutic strategy	793
spinal cord repair	830
one clinical trial	853
the vast majority of fundamental studies	915
the vast majority	915
fundamental studies	936
the recovery of locomotor function	972
the recovery	972
locomotor function	988
the efficiency of this cellular tool for repairing respiratory motor dysfunction , which affects more than half of paraplegic/tetraplegic patients ,	1008
the efficiency	1008
this cellular tool for repairing respiratory motor dysfunction	1026
this cellular tool	1026
respiratory motor dysfunction	1059
more than half of paraplegic/tetraplegic patients	1104
more than half	1104
paraplegic/tetraplegic patients	1122
a rat model that mimics the mechanisms encountered after a cervical contusion that induces a persistent hemi-diaphragmatic paralysis	1178
a rat model	1178
the mechanisms encountered after a cervical contusion that induces a persistent hemi-diaphragmatic paralysis	1202
the mechanisms	1202
a cervical contusion that induces a persistent hemi-diaphragmatic paralysis	1235
a cervical contusion	1235
a persistent hemi-diaphragmatic paralysis	1269
we	1312
the therapeutic efficiency of a delayed transplantation -LRB- 2 weeks post-contusion -RRB- of nasal OECs within the injured spinal cord	1324
the therapeutic efficiency	1324
a delayed transplantation -LRB- 2 weeks post-contusion -RRB- of nasal OECs within the injured spinal cord	1354
a delayed transplantation -LRB- 2 weeks post-contusion -RRB-	1354
a delayed transplantation	1354
2 weeks	1381
nasal OECs within the injured spinal cord	1408
nasal OECs	1408
the injured spinal cord	1426
Functional recovery	1451
respiratory behavior tests , diaphragmatic electromyography and neuro-electrophysiological recording of the phrenic motoneurons	1491
respiratory behavior tests	1491
diaphragmatic electromyography	1519
neuro-electrophysiological recording of the phrenic motoneurons	1554
neuro-electrophysiological recording	1554
the phrenic motoneurons	1594
axogenesis	1624
immunohistochemistry	1655
We	1677
3 months post-transplantation , nasal OECs	1690
3 months	1690
post-transplantation , nasal OECs	1699
breathing movements , ii -RRB- activities of the ipsilateral diaphragm and corresponding phrenic nerve	1743
breathing movements	1743
ii -RRB- activities of the ipsilateral diaphragm	1764
activities	1768
the ipsilateral diaphragm	1782
corresponding phrenic nerve	1812
the injury site	1870
We	1887
this functional partial recovery	1912
the restoration of ipsilateral supraspinal command	1960
the restoration	1960
ipsilateral supraspinal command	1979
Our study	2012
further evidence	2029
olfactory ensheathing cells	2051
clinical application	2090
tetraplegic patients with impaired breathing movements	2125
tetraplegic patients	2125
impaired breathing movements	2151
This article	2181
part of a Special Issue entitled	2197
part	2197
a Special Issue entitled	2205
a Special Issue	2205
olfactory ensheathing glia and their prospect for nervous system repair	2245
olfactory ensheathing glia	2245
their prospect for nervous system repair	2276
their prospect	2276
nervous system repair	2295
Introduction Spinal cord injury -LRB- SCI -RRB-	2319
Introduction Spinal cord injury	2319
Introduction	2319
Spinal cord injury	2332
SCI	2352
one of the leading causes of disabilities in young adults	2360
one	2360
the leading causes of disabilities in young adults	2367
the leading causes	2367
disabilities in young adults	2389
disabilities	2389
young adults	2405
An impaired transmission in sensory-motor neurons , including autonomic neurons ,	2419
An impaired transmission	2419
sensory-motor neurons	2447
autonomic neurons	2480
functional deficits and compromises life expectancy	2507
functional deficits	2507
compromises life expectancy	2531
Cervical injuries , which account for half of SCI cases -LRB- Jackson et al. , 2004 -RRB- ,	2560
Cervical injuries	2560
half of SCI cases -LRB- Jackson et al. , 2004 -RRB-	2597
half	2597
SCI cases -LRB- Jackson et al. , 2004 -RRB-	2605
SCI cases	2605
Jackson	2616
et al. , 2004	2624
et al.	2624
2004	2632
the most debilitating because they generally sever the bulbo-spinal respiratory drive to phrenic motoneuron pools -LRB- C3 -- C5 -RRB- and , as a consequence , generate a diaphragm dysfunction	2643
they	2673
the bulbo-spinal respiratory drive	2694
phrenic motoneuron pools -LRB- C3 -- C5 -RRB-	2732
phrenic motoneuron pools	2732
C3 -- C5	2758
C3	2758
C5	2761
a consequence	2773
a diaphragm	2797
injured individuals	2841
intensive post-SCI carewith	2869
chronic respiratory ventilation assistance -LRB- Berlly and Shem , 2007 -RRB-	2897
chronic respiratory ventilation assistance	2897
Berlly and Shem	2941
2007	2958
Respiratory symptoms	2965
reduced vital capacity and secondary complications such as pulmonary infections -LRB- Berlly and Shem , 2007 ; Brown et al. , 2006 -RRB-	2994
reduced vital capacity	2994
secondary complications such as pulmonary infections -LRB- Berlly and Shem , 2007 ; Brown et al. , 2006 -RRB-	3021
secondary complications	3021
pulmonary infections -LRB- Berlly and Shem , 2007 ; Brown et al. , 2006 -RRB-	3053
pulmonary infections	3053
Berlly and Shem , 2007 ; Brown et al. , 2006	3075
Berlly and Shem	3075
2007 ; Brown et al.	3092
2007	3092
Brown et al.	3098
Brown	3098
et al.	3104
2006	3112
It	3119
prime importance	3138
strategies aiming to restore respiratory capacities	3166
strategies	3166
respiratory capacities	3195
effective treatments for SCI	3228
effective treatments	3228
SCI	3253
most recently rehabilitative strategies such as cellular and molecular therapies	3270
most recently rehabilitative strategies	3270
cellular and molecular therapies	3318
animalmodels andsome clinical trials have been initiated	3371
animalmodels	3371
andsome clinical trials	3384
Implantation of olfactory ensheathing cells -LRB- OECs -RRB-	3429
Implantation of olfactory ensheathing cells	3429
Implantation	3429
olfactory ensheathing cells	3445
OECs	3474
one of themostpromising -LRB- Kocsis et al. , 2009 ; Raisman andLi , 2007 -RRB-	3492
one	3492
themostpromising -LRB- Kocsis et al. , 2009 ; Raisman andLi , 2007 -RRB-	3499
themostpromising	3499
Kocsis	3516
et al. , 2009 ; Raisman andLi , 2007	3523
et al.	3523
2009 ; Raisman andLi	3531
2009	3531
Raisman andLi	3536
2007	3551
the majority of the transplantation studies	3563
the majority	3563
the transplantation studies	3579
olfactory bulb-derived OECs -LRB- central -RRB-	3617
olfactory bulb-derived OECs	3617
central	3646
OECs	3655
fromthe lamina propria of the olfactory mucosa -LRB- peripheral -RRB- by nasal biopsy -LRB- Bianco et al. , 2004 ; Richter and Roskams , 2008 -RRB-	3681
fromthe lamina propria	3681
the olfactory mucosa -LRB- peripheral -RRB- by nasal biopsy -LRB- Bianco et al. , 2004 ; Richter and Roskams , 2008 -RRB-	3707
the olfactory mucosa -LRB- peripheral -RRB-	3707
the olfactory mucosa	3707
peripheral	3729
nasal biopsy -LRB- Bianco et al. , 2004 ; Richter and Roskams , 2008 -RRB-	3744
nasal biopsy	3744
Bianco	3758
et al. , 2004 ; Richter and Roskams , 2008	3765
et al.	3765
2004 ; Richter and Roskams	3773
2004	3773
Richter and Roskams	3779
2008	3800
The olfactory mucosa cells	3807
paraplegic patients	3881
a phase I	3908
a phase	3908
I	3916
IIa clinical trial -LRB- Feron et al. , 2005 ; Mackay-Simet al. , 2008 -RRB-	3919
IIa	3919
clinical trial -LRB- Feron et al. , 2005 ; Mackay-Simet al. , 2008 -RRB-	3923
clinical trial	3923
Feron	3939
et al. , 2005 ; Mackay-Simet al. , 2008	3945
et al.	3945
2005 ; Mackay-Simet al.	3953
2005	3953
Mackay-Simet al.	3958
Mackay-Simet	3958
al.	3971
2008	3976
addition	3986
there	3996
no associated co-morbidity	4005
it	4038
olfactory biopsies	4061
the sense of smell -LRB- Feron et al. , 1998 -RRB-	4094
the sense	4094
smell -LRB- Feron et al. , 1998 -RRB-	4107
smell	4107
Feron	4114
et al. , 1998	4120
et al.	4120
1998	4128
We	4135
a cervical spinal cord contusion model	4162
the observed respiratory deficit after SCI -LRB- Baussart et al. , 2006 -RRB-	4213
the observed respiratory deficit	4213
SCI -LRB- Baussart et al. , 2006 -RRB-	4252
SCI	4252
Baussart	4257
et al. , 2006	4266
et al.	4266
2006	4274
This rat model	4281
a persistent , reproducible and quantifiable diaphragm respiratory deficit	4304
a persistent , reproducible and quantifiable diaphragm	4304
respiratory deficit	4358
It	4379
a unique experimental model of high cervical contusion dedicated to assess the efficiency of cell transplantation on breathing recovery after cervical SCI	4385
a unique experimental model	4385
high cervical contusion dedicated to assess the efficiency of cell transplantation on breathing recovery after cervical SCI	4416
high cervical contusion	4416
the efficiency of cell transplantation	4460
the efficiency	4460
cell transplantation	4478
breathing recovery	4502
cervical SCI	4527
the current study	4544
we	4563
a delayed transplantation of nasal OECs	4586
a delayed transplantation	4586
nasal OECs	4615
respiratory recovery	4634
Functional recovery of breathing	4656
Functional recovery	4656
breathing	4679
3 months	4702
respiratory behavioural plethysmography and EMG	4739
the diaphragm	4790
Activity of phrenic nerve and immunohistochemistry	4805
Activity	4805
phrenic nerve and immunohistochemistry	4817
reorganizational changes	4877
the cervical cord	4905
Materials and methods Animal care and handling	4925
Materials	4925
methods Animal care and handling	4939
methods	4939
Animal care and handling	4947
accordance	4990
the Guide for the Care and Use of Laboratory Animals , the Guidelines for the Use of Animals in Neuroscience Research and French laws relevant to animal experiments and surgery -LRB- accreditation no	5006
the Guide for the Care and Use of Laboratory Animals	5006
the Guide	5006
the Care and Use	5020
Laboratory Animals	5040
the Guidelines for the Use of Animals in Neuroscience Research and French laws relevant to animal experiments	5060
the Guidelines	5060
the Use of Animals in Neuroscience Research and French laws relevant to animal experiments	5079
the Use	5079
Animals in Neuroscience Research and French laws relevant to animal experiments	5090
Animals	5090
Neuroscience Research and French laws relevant to animal experiments	5101
Neuroscience Research and French laws	5101
animal experiments	5151
surgery -LRB- accreditation no	5174
surgery	5174
accreditation no	5183
accreditation	5183
no	5197
C13-055-6 from the French Ministry of Agriculture -RRB- .	5201
C13-055-6	5201
the French Ministry of Agriculture -RRB-	5216
the French Ministry	5216
Agriculture	5239
Primary culture and purification of nasal OECs Five male inbred Sprague Dawley adult rats	5253
Primary culture and purification	5253
nasal OECs Five male inbred Sprague Dawley adult rats	5289
nasal OECs	5289
Five male inbred Sprague Dawley adult rats	5300
250 g	5353
Janvier	5371
France	5380
Cultures of OECs	5389
Cultures	5389
OECs	5401
as previously described -LRB- Bianco et al. , 2004 ; Lu et al. , 2001 -RRB-	5420
as previously described	5420
as previously	5420
Bianco	5445
et al. , 2004 ; Lu et al. , 2001	5452
et al.	5452
2004 ; Lu et al.	5460
2004	5460
Lu et al.	5466
Lu	5466
et al.	5469
2001	5477
the lamina propria	5493
cells	5532
DMEM/HAMF12 supplemented with 10 % foetal calf serum and plated on poly-L-lysine -LRB- 2 μg/cm2 -RRB- coated dishes	5559
DMEM/HAMF12	5559
10 % foetal calf serum	5589
poly-L-lysine -LRB- 2 μg/cm2 -RRB-	5625
poly-L-lysine	5625
2 μg/cm2	5640
coated dishes	5650
Two days later	5665
the culture medium	5681
serum-free medium supplemented with neurotrophin 3 -LRB- NT3 , 50 ng/ml -RRB- , which is known to enhance survival of OECs in culture with their purity approaching 100 % -LRB- Bianco et al. , 2004 -RRB-	5716
serum-free medium	5716
neurotrophin 3 -LRB- NT3 , 50 ng/ml -RRB- , which is known to enhance survival of OECs in culture with their purity approaching 100 % -LRB- Bianco et al. , 2004 -RRB-	5752
neurotrophin 3 -LRB- NT3 , 50 ng/ml -RRB-	5752
neurotrophin 3	5752
NT3 , 50 ng/ml	5768
NT3	5768
50 ng/ml	5773
survival of OECs in culture	5809
survival	5809
OECs in culture	5821
OECs	5821
culture	5829
their purity approaching 100 % -LRB- Bianco et al. , 2004 -RRB-	5842
their purity	5842
100 % -LRB- Bianco et al. , 2004 -RRB-	5867
100 %	5867
Bianco	5873
et al. , 2004	5880
et al.	5880
2004	5888
90 % of cells in the OEC	5900
90 %	5900
cells in the OEC	5907
cells	5907
the OEC	5916
cultures	5924
p75NFR and GFAP immunoreactive	5938
p75NFR and GFAP	5938
a control for contaminationwith Schwann cells myelinatingmotor axons	5973
a control	5973
contaminationwith Schwann cells myelinatingmotor axons	5987
contaminationwith Schwann cells	5987
myelinatingmotor axons	6019
cultures	6043
HNK1 antibody -LRB- Sigma Castle Hill , NSW , Australia -RRB-	6088
HNK1 antibody	6088
Sigma Castle Hill	6103
NSW	6122
Australia	6127
this testing	6148
contamination	6180
sensory axon-myelinating or non-myelinating Schwann cells , which are known to lack the HNK1 epitope -LRB- Bock et al. , 2007 ; Martini et al. , 1994 ; Saito et al. , 2005 -RRB- Surgical procedures Female adult Sprague Dawley rats , weighing 250 g at the start of the experiment , were used	6199
sensory axon-myelinating or non-myelinating Schwann cells	6199
the HNK1 epitope -LRB- Bock et al. , 2007 ; Martini et al. , 1994 ; Saito et al. , 2005 -RRB-	6282
the HNK1 epitope	6282
Bock et al. , 2007 ; Martini et al. , 1994 ; Saito et al. , 2005	6300
Bock	6300
et al. , 2007 ; Martini et al. , 1994 ; Saito et al. , 2005	6305
et al. , 2007	6305
et al.	6305
2007	6313
Martini et al. , 1994	6319
Martini	6319
et al. , 1994	6327
et al.	6327
1994	6335
Saito et al. , 2005	6341
Saito	6341
et al. , 2005	6347
et al.	6347
2005	6355
Surgical procedures Female adult Sprague Dawley rats , weighing 250 g at the start of the experiment , were used	6361
Surgical procedures	6361
Female adult Sprague Dawley rats , weighing 250 g at the start of the experiment ,	6381
Female adult Sprague Dawley rats	6381
250 g at the start of the experiment	6424
250 g	6424
the start of the experiment	6433
the start	6433
the experiment	6446
Janvier	6473
France	6482
putative cell rejection	6509
we	6534
inbred littermates	6542
both donor and receiver animals	6565
Anesthesia	6598
pentobarbital -LRB- Nembutal , 50 mg/kg , ip ; Sanofi , France -RRB-	6645
pentobarbital	6645
Nembutal , 50 mg/kg	6660
Nembutal	6660
50 mg/kg	6670
ip ; Sanofi , France	6680
ip	6680
Sanofi , France	6684
Cervical contusion was performed as previously described -LRB- Baussart et al. , 2006 -RRB- for	6701
Cervical contusion	6701
Baussart et al. , 2006	6759
Baussart	6759
et al.	6768
2006	6776
control rats -LRB- n = 4 -RRB- , MEDIUM and OEC rat groups -LRB- n = 6 for each group -RRB-	6795
control rats -LRB- n = 4 -RRB-	6795
control rats	6795
n	6809
4	6811
MEDIUM	6815
OEC rat groups -LRB- n = 6 for each group -RRB-	6826
OEC rat groups	6826
n = 6 for each group	6842
n = 6	6842
n	6842
6	6844
each group	6850
a midline dorsal cervical incision	6880
a midline dorsal	6880
cervical incision	6897
a standard bilateral C2 laminectomy	6916
great care	6971
the left part of the vertebra	7008
the left part	7008
the vertebra	7025
the far-lateral part of the left spinal cord	7061
the far-lateral part	7061
the left spinal cord	7085
The dura	7107
the level of the left C2 dorsal root -LRB- window of 2.5 × 2.5 mm -RRB-	7159
the level	7159
the left C2 dorsal root -LRB- window of 2.5 × 2.5 mm -RRB-	7172
the left C2 dorsal root	7172
window of 2.5 × 2.5 mm	7197
window of 2.5 ×	7197
window	7197
2.5 ×	7207
2.5 mm	7211
a dorso-lateral resection of the pia matter	7223
a dorso-lateral resection	7223
the pia matter	7252
microscissors in order to remove a fragment measuring around 1 mm -LRB- transversal axis corresponding to the half-lateral part of the left C2 hemispinal cord -RRB- × 1 mm -LRB- rostrocaudal axis -RRB-	7288
microscissors	7288
order to remove a fragment measuring around 1 mm -LRB- transversal axis corresponding to the half-lateral part of the left C2 hemispinal cord -RRB- × 1 mm	7305
a fragment measuring around 1 mm -LRB- transversal axis corresponding to the half-lateral part of the left C2 hemispinal cord -RRB-	7321
a fragment	7321
1 mm -LRB- transversal axis corresponding to the half-lateral part of the left C2 hemispinal cord -RRB-	7349
1 mm	7349
transversal axis corresponding to the half-lateral part of the left C2 hemispinal cord	7355
transversal axis corresponding	7355
the half-lateral part of the left C2 hemispinal cord	7389
the half-lateral part	7389
the left C2 hemispinal cord	7414
1 mm	7443
rostrocaudal axis	7449
The aim of partly removing the pia matter	7469
The aim	7469
the pia matter	7496
the shock absorption	7525
the pia matter	7549
the damage	7586
the ventrolateral white matter	7600
The injury	7632
the left C2 dorsal root	7669
the operating microscope	7699
A 0.8 mm-diameter , 120 mm-long metallic rod -LRB- referred as the impactor -RRB-	7725
A 0.8 mm-diameter	7725
120 mm-long metallic rod	7744
the impactor	7782
the left C2 spinal cord	7811
the level of the pia matter window	7838
the level	7838
the pia matter window	7851
3 mm depth	7903
the floor of the C2 vertebral body	7922
the floor	7922
the C2 vertebral body	7935
A 20 g weight	7958
the impactor	7990
a height of 12 cm	8008
a height	8008
12 cm	8020
The compression	8027
30 min with the 20 g weight	8062
30 min	8062
the 20 g weight	8074
the impactor	8112
the wound	8149
drainage	8178
betadine	8207
This injury	8217
a persistent and reproductible hemi-diaphragm paralysis	8238
Cell transplantation Fifteen days post-injury	8295
Cell transplantation	8295
Fifteen days	8316
rats	8342
the same procedure as paragraph 2.2	8373
the same procedure	8373
paragraph 2.2	8395
surgical access	8428
the injured region	8447
cells	8467
a 5 μl	8505
Hamilton glass syringe	8512
a 27 gauge needle	8549
a micromanipulator	8583
MEDIUM animals	8603
injection of DMEM / HAMF12	8627
injection	8627
DMEM / HAMF12	8640
DMEM	8640
HAMF12	8646
transplanted animals	8658
OECs	8688
Medium or cells in the same medium	8694
Medium or cells	8694
the same medium	8713
the spinal cord on the site of the lesion	8746
the spinal cord	8746
the site of the lesion	8765
the site	8765
the lesion	8777
Injectionswere	8789
spinal sites 1.5 mmlaterally fromthe midline : 1 mm rostrally , 1.5 -- 2 mm caudally	8817
spinal sites	8817
1.5 mmlaterally fromthe midline : 1 mm rostrally , 1.5 -- 2 mm caudally	8830
1.5 mmlaterally fromthe midline	8830
1.5	8830
fromthe midline	8846
1 mm rostrally , 1.5	8863
1 mm rostrally	8863
1 mm	8863
1.5	8879
2 mm caudally	8883
2 mm	8883
the lesion	8907
the ventral and ventrolateral funiculi where the descending respiratory pathways are located	8928
the ventral and ventrolateral funiculi	8928
the descending respiratory pathways	8973
each spinal site	9022
two injections -LRB- 0.5 μl each -RRB-	9048
two injections	9048
0.5 μl each	9064
0.5 μl	9064
each	9071
2 and 3 mm	9086
the dorsal surface of the cord	9103
the dorsal surface	9103
the cord	9125
Each animal	9135
a total of 6 injections -LRB- 6 × 0.5 μl -RRB- which contained OEC suspension -LRB- 100,000 cells/μl -RRB- or DMEM/HAMF12	9156
a total	9156
6 injections -LRB- 6 × 0.5 μl -RRB- which contained OEC suspension -LRB- 100,000 cells/μl -RRB- or DMEM/HAMF12	9167
6 injections	9167
6 × 0.5 μl	9181
6 ×	9181
0.5 μl	9183
OEC suspension -LRB- 100,000 cells/μl -RRB- or DMEM/HAMF12	9206
OEC suspension	9206
100,000 cells/μl	9222
DMEM/HAMF12	9243
The injection	9256
0.5 μl/min	9283
The syringe	9295
the injection site for 2 min	9319
the injection site	9319
2 min	9342
reflux	9357
No immunosuppressant	9365
Plethysmography Ventilation	9396
awake unrestrained MEDIUM and OEC rats	9440
barometric plethysmography	9485
Control rats -LRB- uninjured -RRB-	9513
Control rats	9513
comparison -LRB- n = 5 -RRB-	9552
comparison	9552
n	9564
5	9566
the protocol described previously -LRB- Peyronnet et al. , 2000 -RRB-	9583
the protocol	9583
Peyronnet et al. , 2000	9618
Peyronnet	9618
et al.	9628
2000	9636
calibration of the chamber	9643
calibration	9643
the chamber	9658
the animal	9698
the box	9712
a MEDIUM or an OEC rat	9728
a MEDIUM	9728
an OEC rat	9740
the chamber for measurements of ventilation	9765
the chamber	9765
measurements of ventilation	9781
measurements	9781
ventilation	9797
Tidal volume , respiratory frequency and minute ventilation	9810
Tidal volume	9810
respiratory frequency	9824
minute ventilation	9850
breath-by-breath over 30 -- 50 consecutive cycles -LRB- around 30 s -RRB-	9890
breath-by-breath	9890
30 -- 50 consecutive cycles -LRB- around 30 s -RRB-	9912
30	9912
50 consecutive cycles	9915
30 s	9945
computer analysis of the spirogram	9954
computer analysis	9954
the spirogram	9975
All measurements in normoxia	9990
All measurements	9990
normoxia	10010
quadruplet for each rat	10037
quadruplet	10037
each rat	10052
The mean of these 4 values	10062
The mean	10062
these 4 values	10074
the basal ventilation	10107
The hypoxic test	10130
the plethysmograph chamber	10175
a mixture of 10 % O2 and 90 % N2	10207
a mixture	10207
10 %	10220
O2 and 90 % N2	10224
O2	10224
90 % N2	10231
the 10 % O2 level was reached inside the chamber	10245
the 10 %	10245
O2 level	10253
the chamber	10281
the system	10294
the measurements -LRB- at 1 , 4 , 7 and 10 min after the beginning of hypoxia -RRB- of the hypoxic ventilatory response involving 40 -- 60 breath cycles for each recordings	10328
the measurements	10328
1 , 4 , 7 and 10 min after the beginning of hypoxia	10349
1	10349
4	10352
7	10355
10 min after the beginning of hypoxia	10361
10 min	10361
the beginning of hypoxia	10374
the beginning	10374
hypoxia	10391
the hypoxic ventilatory response involving 40 -- 60 breath cycles for each recordings	10403
the hypoxic ventilatory response	10403
40 -- 60 breath cycles for each recordings	10446
40	10446
60 breath cycles for each recordings	10449
60 breath cycles	10449
each recordings	10470
The mean of these 4 measurements	10487
The mean	10487
these 4 measurements	10499
ventilation in hypoxia	10531
ventilation	10531
hypoxia	10546
Diaphragm electromyography Three months post-grafting	10555
Diaphragm electromyography	10555
Three months post-grafting	10582
the animals -LRB- 300 -- 400 g -RRB-	10610
the animals	10610
300 -- 400 g	10623
300	10623
400 g	10627
Diaphragm electromyography -LRB- EMG -RRB- and integrated signal -LRB- Int EMG -RRB- activity of both right and left -LRB- ispilateral to the lesion -RRB- hemi-diaphragms were recorded as previously described -LRB- Polentes et al. , 2004 -RRB- .	10672
Diaphragm electromyography -LRB- EMG -RRB- and integrated signal -LRB- Int EMG -RRB- activity of both right and left -LRB- ispilateral to the lesion -RRB- hemi-diaphragms were recorded as previously	10672
Diaphragm electromyography -LRB- EMG -RRB-	10672
Diaphragm electromyography	10672
EMG	10700
integrated signal -LRB- Int EMG -RRB- activity of both right and left -LRB- ispilateral to the lesion -RRB- hemi-diaphragms were recorded as previously	10709
integrated signal -LRB- Int EMG -RRB-	10709
integrated signal	10709
Int EMG	10728
activity of both right and left -LRB- ispilateral to the lesion -RRB- hemi-diaphragms were recorded as previously	10737
activity	10737
both right and left -LRB- ispilateral to the lesion -RRB- hemi-diaphragms	10749
the lesion	10785
Polentes et al. , 2004	10852
Polentes	10852
et al.	10861
2004	10869
The diaphragm EMG	10876
spontaneous breathing -LRB- eupnea -RRB-	10913
spontaneous breathing	10913
eupnea	10936
imposed hypercapnic conditions	10955
a 15 cm tube	10998
the tracheal canula	11014
End tidal CO2	11035
a check mate	11069
9900 -LRB- PBI Dansensor -RRB-	11082
9900	11082
PBI Dansensor	11088
4.8 % to 5.2 % in eupnea	11119
4.8 % to 5.2 %	11119
eupnea	11135
7	11145
7.5 % during imposed asphyxic conditions	11147
7.5 %	11147
imposed asphyxic conditions	11159
animals	11214
Phrenic nerves	11223
the EMG recordings	11262
the animals	11282
agent : Gallamine triethiodide , 10mg/kg , iv ; Rhône - Poulenc Rorer , France	11333
agent	11333
Gallamine triethiodide , 10mg/kg , iv	11340
Gallamine triethiodide	11340
10mg/kg	11364
iv	11373
Rhône	11377
Poulenc Rorer , France	11384
Poulenc Rorer	11384
France	11399
Spontaneous activity of both left -LRB- ipsilateral to the lesion -RRB- and right phrenic nerves	11423
Spontaneous activity	11423
both left -LRB- ipsilateral to the lesion -RRB- and right phrenic nerves	11447
the lesion	11473
phrenic neurogram , PN ; integrated PN , int PN	11525
phrenic neurogram	11525
PN ; integrated PN , int PN	11544
PN	11544
integrated PN , int PN	11548
integrated PN	11548
int PN	11563
Polentes et al. , 2004	11596
Polentes	11596
et al.	11605
2004	11613
eupnea and hypercapnia	11626
The spinal cord connectivity	11650
phrenic orthodromic activation elicited by supralesional spinal cord stimulation -LRB- tungsten bipolar electrodes : Frederik Haer , 10 kΩ -RRB- of the C1 ventral and ventrolateral funiculi , as previously described -LRB- Gauthier and Monteau , 1986 ; Polentes et al. , 2004 -RRB-	11696
phrenic orthodromic activation	11696
supralesional spinal cord stimulation -LRB- tungsten bipolar electrodes : Frederik Haer , 10 kΩ -RRB- of the C1 ventral and ventrolateral funiculi , as previously described -LRB- Gauthier and Monteau , 1986 ; Polentes et al. , 2004 -RRB-	11739
supralesional spinal cord stimulation -LRB- tungsten bipolar electrodes : Frederik Haer , 10 kΩ -RRB-	11739
supralesional spinal cord stimulation	11739
tungsten bipolar electrodes : Frederik Haer , 10 kΩ	11778
tungsten bipolar electrodes	11778
Frederik Haer , 10 kΩ	11807
Frederik Haer	11807
10 kΩ	11822
the C1 ventral and ventrolateral funiculi , as previously described	11832
the C1 ventral and ventrolateral funiculi	11832
the C1	11832
ventral and ventrolateral funiculi	11839
Gauthier and Monteau , 1986 ; Polentes et al. , 2004	11900
Gauthier and Monteau	11900
1986 ; Polentes et al.	11922
1986	11922
Polentes et al.	11928
Polentes	11928
et al.	11937
2004	11945
These spinal areas	11952
respiratory bulbo-spinal axons which form monosynaptic connections with phrenic motoneurons -LRB- Lipski et al. , 1994 ; Speck , 1988 -RRB-	11990
respiratory bulbo-spinal axons	11990
monosynaptic connections	12032
phrenic motoneurons -LRB- Lipski et al. , 1994 ; Speck , 1988 -RRB-	12062
phrenic motoneurons	12062
Lipski	12083
et al. , 1994 ; Speck , 1988	12090
et al.	12090
1994 ; Speck	12098
1994	12098
Speck	12104
1988	12111
Acute sections at the C1 cervical level	12118
Acute sections	12118
the C1 cervical level	12136
the end of this invasive surgery/electrophysiology procedure	12176
the end	12176
this invasive surgery/electrophysiology procedure	12187
the healthy state -LRB- EKG , temperature , myosis -RRB- of the animal	12245
the healthy state -LRB- EKG , temperature , myosis -RRB-	12245
the healthy state	12245
EKG	12264
temperature	12269
myosis	12282
the animal	12293
transcardiac perfusion	12321
immunohistochemistry	12362
each condition	12387
3 animals	12403
these healthy criteria	12432
acute sections	12483
All signalsweremonitoredonaGould oscilloscope -LRB- Gould 1604 -RRB- and computer	12521
All signalsweremonitoredonaGould oscilloscope -LRB- Gould 1604 -RRB-	12521
All signalsweremonitoredonaGould oscilloscope	12521
Gould 1604	12568
computer	12584
the Gould Transition software -LRB- Designed by P. Sanchez , CNRS -RRB-	12608
the Gould Transition software	12608
P. Sanchez , CNRS	12651
P. Sanchez	12651
CNRS	12663
Quantitative aspects of diaphragm and phrenic nerve activity Twelve different recording sites	12670
Quantitative aspects of diaphragm	12670
Quantitative aspects	12670
diaphragm	12694
phrenic nerve activity Twelve different recording sites	12708
phrenic nerve activity	12708
Twelve different recording sites	12731
Twelve	12731
the EMG activity of each hemi-diaphragm	12783
the EMG activity	12783
each hemi-diaphragm	12803
the degree of activity of the left diaphragm	12836
the degree	12836
activity of the left diaphragm	12850
activity	12850
the left diaphragm	12862
ipsilateral to the spinal injury , the area of each rectified and integrated trace under the diaphragm EMG	12882
ipsilateral	12882
the spinal injury , the area of each rectified and integrated trace under the diaphragm EMG	12897
the spinal injury	12897
the area of each rectified	12916
the area	12916
each rectified	12928
each	12928
integrated trace under the diaphragm EMG	12947
integrated trace	12947
the diaphragm EMG	12970
a software specifically designed -LRB- Dr. P. Sanchez , CNRS -RRB-	13009
a software	13009
Dr. P. Sanchez	13043
CNRS	13059
any deflection of the rectified and integrated traces due to artefactual incidence , such as deflections due to EKG in sites near the heart	13076
any deflection	13076
the rectified and integrated traces due to artefactual incidence , such as deflections due to EKG in sites near the heart	13094
the rectified	13094
the	13094
integrated traces due to artefactual incidence	13112
integrated traces	13112
artefactual incidence	13137
deflections due to EKG in sites near the heart	13168
deflections	13168
EKG in sites near the heart	13187
EKG	13187
sites near the heart	13194
sites	13194
the heart	13205
The 12 recording sites	13216
a substantial area of the parts of the muscle involved in breathing activity , that is , the pars sternalis , the rostral pars costalis and the rostral part of the lumbar diaphragm which surrounds the level of the cava vein	13245
a substantial area	13245
the parts of the muscle involved in breathing activity , that is , the pars sternalis , the rostral pars costalis and the rostral part of the lumbar diaphragm which surrounds the level of the cava vein	13267
the parts	13267
the muscle	13280
breathing activity , that is	13303
breathing activity	13303
the pars sternalis	13332
the rostral pars costalis	13352
the rostral part of the lumbar diaphragm which surrounds the level of the cava vein	13382
the rostral part	13382
the lumbar diaphragm	13402
the level of the cava vein	13439
the level	13439
the cava vein	13452
each recording site	13471
the	13492
area of five characteristic successive EMG rectified and integrated traces	13505
area of five characteristic successive EMG rectified	13505
area	13505
five characteristic successive EMG rectified	13513
five characteristic successive EMG	13513
integrated traces	13562
each recording site	13600
the left	13621
rectified and integrated area	13639
a percentage of the corresponding right rectified and integrated surface -LRB- % left/right -RRB-	13687
a percentage	13687
the corresponding right rectified and integrated surface -LRB- % left/right -RRB-	13703
the corresponding right rectified and integrated surface	13703
% left/right	13761
each animal	13780
the mean	13793
EMG diaphragm activity	13807
the average of the 12 recording sites -LRB- % left/right -RRB-	13848
the average	13848
the 12 recording sites -LRB- % left/right -RRB-	13863
the 12 recording sites	13863
% left/right	13887
the activity of the left phrenic nerve ipsilateral	13914
the activity	13914
the left phrenic nerve ipsilateral	13930
the lesion	13968
five successive typical phrenic bursts	13980
the average surface of their rectified and integrated traces	14037
the average surface of their rectified	14037
the average surface	14037
their	14060
integrated traces	14080
the same software	14119
diaphragm EMG	14144
each rat	14163
each step of the experiment	14181
each step	14181
the experiment	14194
the left	14210
phrenic nerve activity	14253
a percentage of the corresponding right rectified and integrated surface -LRB- % left/right -RRB-	14294
a percentage	14294
the corresponding right rectified and integrated surface -LRB- % left/right -RRB-	14310
the corresponding right rectified and integrated surface	14310
% left/right	14368
each animal	14386
the right phrenic nerve activity	14399
a reference	14445
the left one	14469
chronic conditions	14488
intervariability	14519
Immunohistochemistry Longitudinal/horizontal sections of the cervical spinal cord of 30 μm	14537
Immunohistochemistry Longitudinal/horizontal sections	14537
the cervical spinal cord of 30 μm	14594
the cervical spinal cord	14594
30 μm	14622
a cryostat	14640
two rinses in 0.1 M PBS	14662
two rinses	14662
0.1 M PBS	14676
sections on slides	14687
sections	14687
slides	14699
0.1 MPBS containing 0.2 % Triton X-100 for 30 min	14731
0.1 MPBS	14731
0.2 % Triton X-100 for 30 min	14750
0.2 % Triton X-100	14750
30 min	14772
Sections	14780
1 h	14812
0.1 M PBS containing 4 % of goat serum and incubated overnight at 4 °C with the corresponding primary antibody : rabbit anti-serotonin -LRB- 1/2000 , Sigma , USA -RRB-	14819
0.1 M PBS	14819
4 % of goat serum	14840
4 %	14840
goat serum	14846
overnight at 4 °C	14871
overnight	14871
4 °C	14884
the corresponding primary antibody	14894
rabbit anti-serotonin -LRB- 1/2000 , Sigma , USA -RRB-	14930
rabbit anti-serotonin	14930
1/2000	14953
Sigma	14961
USA	14968
mouse anti-neurofilament H phosphorylated -LRB- 1/1000 , Eurogentec-Covance , USA -RRB- , rabbit anti-GFAP -LRB- 1/1000 ; DAKO , France -RRB- , and rabbit anti-GAP43 -LRB- 1/1000 ; Chemicon , USA -RRB-	14974
mouse anti-neurofilament H phosphorylated -LRB- 1/1000 , Eurogentec-Covance , USA -RRB-	14974
mouse anti-neurofilament H phosphorylated	14974
mouse anti-neurofilament H	14974
1/1000	15017
Eurogentec-Covance	15025
USA	15045
rabbit anti-GFAP -LRB- 1/1000 ; DAKO , France -RRB-	15051
rabbit anti-GFAP	15051
1/1000 ; DAKO , France	15069
1/1000	15069
DAKO , France	15077
rabbit anti-GAP43 -LRB- 1/1000 ; Chemicon , USA -RRB-	15096
rabbit anti-GAP43	15096
1/1000 ; Chemicon , USA	15115
1/1000	15115
Chemicon , USA	15123
primary antibody incubation	15149
sections	15178
1 h at room temperature with the appropriate secondary antibody : goat anti-mouse Alexa 488 and goat anti-rabbit Alexa 594 -LRB- 1/400 ; Invitrogen , France -RRB-	15202
1 h	15202
room temperature with the appropriate secondary antibody : goat anti-mouse Alexa 488 and goat anti-rabbit Alexa 594 -LRB- 1/400 ; Invitrogen , France -RRB-	15209
room temperature with the appropriate secondary antibody : goat anti-mouse Alexa 488	15209
room temperature with the appropriate secondary antibody	15209
room temperature	15209
the appropriate secondary antibody	15231
goat anti-mouse Alexa 488	15267
goat anti-mouse	15267
Alexa 488	15283
goat anti-rabbit Alexa 594 -LRB- 1/400 ; Invitrogen , France -RRB-	15297
goat anti-rabbit Alexa	15297
594 -LRB- 1/400 ; Invitrogen , France -RRB-	15320
594	15320
1/400 ; Invitrogen , France	15325
1/400	15325
Invitrogen , France	15332
Image analyses Confocal images	15353
Image analyses	15353
Confocal images	15368
a Leica TCS SP2 scanning confocal microscope -LRB- Leica -RRB- equipped with a 10 × lens -LRB- HCX PL APO , NA 0.4 -RRB- , argon -LRB- 488 nm -RRB- and helium -LRB- 543 nm -RRB- lasers and monitored with LCS v2 .61 image acquisition software	15403
a Leica TCS SP2 scanning confocal microscope	15403
Leica	15449
a 10 × lens -LRB- HCX PL APO , NA 0.4 -RRB- , argon -LRB- 488 nm -RRB- and helium -LRB- 543 nm -RRB- lasers	15470
a 10 × lens -LRB- HCX PL APO , NA 0.4 -RRB-	15470
a 10 × lens	15470
HCX PL APO , NA 0.4	15482
HCX PL APO	15482
NA 0.4	15494
argon -LRB- 488 nm -RRB-	15503
argon	15503
488 nm	15510
helium -LRB- 543 nm -RRB- lasers	15522
helium	15522
543 nm	15530
lasers	15538
LCS v2	15564
.61 image acquisition software	15570
longitudinal/horizontal sections	15605
Z-stacks from 10 confocal images -LRB- 1 μm focal spacing -RRB-	15639
Z-stacks	15639
10 confocal images -LRB- 1 μm focal spacing -RRB-	15653
10 confocal images	15653
1 μm focal spacing	15673
1 μm	15673
focal spacing	15678
the C2 level	15710
the lesion site	15729
the GFAP-reactive border	15763
all animals in each treatment group	15793
all animals	15793
each treatment group	15808
confocal images	15830
the ipsilateral -LRB- injured side -RRB- and the corresponding contralateral part -LRB- uninjured side -RRB-	15864
the ipsilateral	15864
injured side	15881
the corresponding contralateral part	15899
uninjured side	15937
Confocal images	15954
0.5 mm above the vertebral floor	16001
0.5 mm	16001
the vertebral floor	16014
the most lateral part of the white matter to the most lateral part of the ventral horn	16060
the most lateral part	16060
the white matter to the most lateral part of the ventral horn	16085
the white matter	16085
the most lateral part of the ventral horn	16105
the most lateral part	16105
the ventral horn	16130
Neurofilament and serotonin immunodensitometry	16148
ImageJ -LRB- NIH software -RRB-	16216
ImageJ	16216
NIH software	16224
Quantification of neurofilament and serotonin pixels within the lesion site	16239
Quantification	16239
neurofilament and serotonin pixels within the lesion site	16257
neurofilament and serotonin pixels	16257
the lesion site	16299
areas	16342
790,000 pixels	16358
splitting RGB channels	16374
neurofilament and serotonin pixels	16409
Images	16445
8 bit type images , binary processed	16470
8 bit type images	16470
a similar threshold	16510
staining between animals	16555
staining	16555
animals	16572
Limit to threshold	16581
Limit	16581
threshold	16590
measurement calculations	16626
pixels	16668
Number of neurofilament and serotonin positive pixels	16676
Number	16676
neurofilament and serotonin positive pixels	16686
neurofilament	16686
serotonin positive pixels	16704
the measure tool of ImageJ software	16754
the measure tool	16754
ImageJ software	16774
Results	16792
1	16805
Histological representation of a lateral compression/contusion of the rat spinal cord at the C2 cervical level .	16808
Histological representation	16808
a lateral compression/contusion of the rat spinal cord	16839
a lateral compression/contusion	16839
the rat spinal cord	16874
the C2 cervical level	16897
A	16920
Drawing	16923
a longitudinal view of the cervical spinal cord with the injury indicated by a large black dot	16942
a longitudinal view	16942
the cervical spinal cord with the injury indicated by a large black dot	16965
the cervical spinal cord	16965
the injury indicated by a large black dot	16995
the injury	16995
a large black dot	17019
The size of the injury	17038
The size	17038
the injury	17050
3 months	17074
B	17096
Violet cresyl on longitudinal/horizontal section	17099
Violet cresyl	17099
longitudinal/horizontal section	17116
3 months post-injury to show the extent of the lesion at the ventral level -LRB- scale bar : 500 μm -RRB-	17162
3 months	17162
the extent of the lesion	17191
the extent	17191
the lesion	17205
the ventral level -LRB- scale bar : 500 μm -RRB-	17219
the ventral level	17219
scale bar : 500 μm	17238
scale bar	17238
500 μm	17249
C	17258
Immunocytochemistry for GAP43 and GFAP	17261
Immunocytochemistry	17261
GAP43 and GFAP	17285
2 days	17314
longitudinal/horizontal sections of the cervical spinal cord -LRB- scale bar : 200 μm -RRB-	17336
longitudinal/horizontal sections	17336
the cervical spinal cord -LRB- scale bar : 200 μm -RRB-	17372
the cervical spinal cord	17372
scale bar : 200 μm	17398
scale bar	17398
200 μm	17409
Fig. 2 .	17419
Fig.	17419
2	17424
Breathing performance of control -LRB- uninjured -RRB- , MEDIUM and OEC-grafted rats 3.5 months post-contusion .	17427
Breathing performance	17427
control -LRB- uninjured -RRB- , MEDIUM and OEC-grafted rats 3.5 months post-contusion	17452
control -LRB- uninjured -RRB-	17452
control	17452
MEDIUM	17473
OEC-grafted rats 3.5 months post-contusion	17484
OEC-grafted rats	17484
3.5 months	17501
Minute ventilation -LRB- A -RRB- , inspiratory frequency -LRB- B -RRB- and tidal volume -LRB- C -RRB-	17528
Minute ventilation -LRB- A -RRB- , inspiratory frequency -LRB- B -RRB- and tidal volume	17528
Minute ventilation -LRB- A -RRB-	17528
Minute ventilation	17528
A	17548
inspiratory frequency -LRB- B -RRB-	17552
inspiratory frequency	17552
B	17575
tidal volume	17582
C	17596
quiet breathing -LRB- normoxia -RRB- and hypoxia -LRB- 10 % O2 -RRB-	17620
quiet breathing	17620
normoxia	17637
hypoxia	17651
10 % O2	17660
10 %	17660
O2	17664
Statistical comparisons	17669
a two-way ANOVA test	17714
Control -LRB- n = 5 -RRB- ; MEDIUM and OEC -LRB- n = 6 -RRB- .	17736
Control	17736
n	17745
5	17747
MEDIUM and OEC -LRB- n = 6 -RRB-	17751
MEDIUM and OEC	17751
n	17767
6	17769
Error bars	17773
SEM	17794
p value < 0.05 ; ** : p value < 0.01	17802
p value	17802
0.05 ; ** : p value <	17810
0.05	17810
p value	17820
0.01	17828
Fig. 3 .	17835
Fig.	17835
3	17840
Diaphragm activities of MEDIUM and OEC-grafted rats 3.5 months post-contusion .	17843
Diaphragm activities of MEDIUM and OEC-grafted rats	17843
Diaphragm activities	17843
MEDIUM and OEC-grafted rats	17867
3.5 months	17895
A and B : Typical EMG activity of left and right hemi-diaphragm in MEDIUM and OECtransplanted rats , during spontaneous breathing -LRB- normoxia -RRB- and imposed asphyxic -LRB- hypercapnia -RRB- conditions ,	17922
A and B	17922
Typical EMG activity of left and right hemi-diaphragm in MEDIUM and OECtransplanted rats , during spontaneous breathing -LRB- normoxia -RRB- and imposed asphyxic -LRB- hypercapnia -RRB- conditions	17931
Typical EMG activity	17931
left and right hemi-diaphragm in MEDIUM and OECtransplanted rats , during spontaneous breathing -LRB- normoxia -RRB- and imposed asphyxic -LRB- hypercapnia -RRB- conditions	17955
left and right hemi-diaphragm in MEDIUM and OECtransplanted rats	17955
left and right hemi-diaphragm	17955
MEDIUM and OECtransplanted rats	17988
spontaneous breathing -LRB- normoxia -RRB-	18028
spontaneous breathing	18028
normoxia	18051
asphyxic -LRB- hypercapnia -RRB- conditions	18073
hypercapnia	18083
Each hemi-diaphragm activity	18121
the diaphragm trace -LRB- EMG -RRB- and the integrated trace -LRB- EMG Int -RRB-	18164
the diaphragm trace -LRB- EMG -RRB-	18164
the diaphragm trace	18164
EMG	18185
the integrated trace -LRB- EMG Int -RRB-	18194
the integrated trace	18194
EMG Int	18216
C : Bar graphs , report diaphragm activity in normoxia and hypercapnia conditions -LRB- n = 6 -RRB- .	18226
C	18226
Bar graphs , report diaphragm activity in normoxia and hypercapnia conditions -LRB- n = 6 -RRB-	18229
Bar graphs	18229
report diaphragm activity in normoxia and hypercapnia conditions -LRB- n = 6 -RRB-	18241
report diaphragm activity	18241
normoxia and hypercapnia conditions -LRB- n = 6 -RRB-	18270
normoxia and hypercapnia conditions	18270
n	18307
6	18309
Statistical comparisons	18313
a Student 's t-test	18358
a Student 's	18358
Error bars	18378
SEM	18399
value	18409
Fig.	18421
Spontaneous	18429
phrenic nerve activities of MEDIUM and OEC-grafted rats 3.5 months post-contusion	18452
phrenic nerve activities of MEDIUM	18452
phrenic nerve activities	18452
MEDIUM	18480
OEC-grafted rats 3.5 months post-contusion	18491
OEC-grafted rats	18491
3.5 months	18508
A : Typical phrenic activity in MEDIUM and OEC-transplanted rats	18535
: Typical phrenic activity in MEDIUM and OEC-transplanted rats	18536
Typical phrenic activity in MEDIUM	18538
Typical phrenic activity	18538
MEDIUM	18566
OEC-transplanted rats	18577
OEC-transplanted	18577
rats	18594
Each phrenic nerve activity	18612
the spontaneous trace -LRB- PN -RRB- and the integrated trace -LRB- Int PN -RRB-	18649
the spontaneous trace -LRB- PN -RRB-	18649
the spontaneous trace	18649
PN	18672
the integrated trace -LRB- Int PN -RRB-	18680
the integrated trace	18680
Int PN	18702
B : Typical left and right phrenic responses from four MEDIUM and OEC animals evoked by supralesional stimulation -LRB- single pulse ; 500 μs , 0.4 mA -RRB- , applied on the left and right side of the spinal cord -LRB- C1 level -RRB- , respectively .	18711
B	18711
Typical left and right phrenic responses from four MEDIUM and OEC animals evoked by supralesional stimulation -LRB- single pulse ; 500 μs , 0.4 mA -RRB- , applied on the left and right side of the spinal cord -LRB- C1 level -RRB- , respectively	18714
Typical left and right phrenic responses	18714
four MEDIUM and OEC animals evoked by supralesional stimulation -LRB- single pulse ; 500 μs , 0.4 mA -RRB- , applied on the left and right side of the spinal cord -LRB- C1 level -RRB- , respectively	18760
four MEDIUM and OEC animals	18760
supralesional stimulation -LRB- single pulse ; 500 μs , 0.4 mA -RRB- , applied on the left and right side of the spinal cord -LRB- C1 level -RRB- , respectively	18798
supralesional stimulation -LRB- single pulse ; 500 μs , 0.4 mA -RRB-	18798
supralesional stimulation	18798
single pulse	18825
500 μs , 0.4 mA	18839
500 μs	18839
0.4 mA	18847
the left and right side of the spinal cord -LRB- C1 level -RRB-	18867
the left and right side	18867
the spinal cord -LRB- C1 level -RRB-	18894
the spinal cord	18894
C1 level	18911
each trace	18939
4 superimposed individual traces	18951
4	18951
individual traces	18966
Dots	19001
stimulation	19015
arrowheads	19028
responses of OEC	19048
responses	19048
OEC	19061
phrenic responses	19070
C and D : Bar graphs indicate the level of phrenic recovery by quantifying spontaneous activity -LRB- n = 6 -RRB- -LRB- C -RRB- or induced activity -LRB- n = 6 -RRB- -LRB- D -RRB- .	19089
C and D	19089
Bar graphs	19098
the level of phrenic recovery	19118
the level	19118
phrenic recovery	19131
spontaneous activity -LRB- n = 6 -RRB- -LRB- C -RRB-	19163
spontaneous activity -LRB- n = 6 -RRB-	19163
spontaneous activity	19163
n	19185
6	19187
C	19191
activity -LRB- n = 6 -RRB- -LRB- D -RRB-	19205
activity -LRB- n = 6 -RRB-	19205
activity	19205
n	19215
6	19217
D	19221
phrenic nerve activity	19230
the right phrenic nerve activity	19267
Statistical comparison	19301
a Student 's t-test	19344
a Student 's	19344
Error bars	19364
SEM	19385
p value < 0.01	19394
p value	19394
0.01	19402
Fig. 5 .	19409
Fig.	19409
5	19414
Effect of acute additional sections on phrenic nerve activities of MEDIUM and OEC-grafted rats 3.5 months post-contusion .	19417
Effect of acute additional sections on phrenic nerve activities of MEDIUM and OEC-grafted rats	19417
Effect	19417
acute additional sections on phrenic nerve activities of MEDIUM and OEC-grafted rats	19427
acute additional sections	19427
phrenic nerve activities of MEDIUM and OEC-grafted rats	19456
phrenic nerve activities	19456
MEDIUM and OEC-grafted rats	19484
3.5 months	19512
A and B : Typical phrenic spontaneous activity in MEDIUM -LRB- A -RRB- and OEC-transplanted rats -LRB- B -RRB- , before and after acute sections , is reported .	19539
A and B	19539
Typical phrenic spontaneous activity in MEDIUM -LRB- A -RRB- and OEC-transplanted rats -LRB- B -RRB- , before and after acute sections ,	19548
Typical phrenic spontaneous activity	19548
MEDIUM -LRB- A -RRB- and OEC-transplanted rats -LRB- B -RRB-	19588
MEDIUM	19588
A	19596
OEC-transplanted rats	19603
B	19626
acute sections	19647
Each phrenic nerve activity	19676
the spontaneous trace -LRB- PN -RRB- and the integrated trace -LRB- Int PN -RRB-	19713
the spontaneous trace -LRB- PN -RRB-	19713
the spontaneous trace	19713
PN	19736
the integrated trace -LRB- Int PN -RRB-	19744
the integrated trace	19744
Int PN	19766
The drawing	19775
a dorso-longitudinal view of the cervical spinal cord	19798
a dorso-longitudinal view	19798
the cervical spinal cord	19827
the contusion injury site indicated by a large black dot and the horizontal black line	19858
the contusion injury site	19858
a large black dot and the horizontal black line	19897
a large black dot	19897
the horizontal black line	19919
the extent of C1	19956
the extent	19956
C1	19970
acute sections -LRB- contralateral right medial , right complete or complete section -RRB-	19973
acute sections	19973
C	20054
Plot graph	20057
the remaining right	20076
nerve activities of MEDIUM and OEC-transplanted rats	20105
nerve activities	20105
MEDIUM and OEC-transplanted rats	20125
various acute C1 sections -LRB- n = 3 -RRB-	20165
various acute C1 sections	20165
n	20192
3	20194
Statistical comparison	20198
a two-way ANOVA test	20241
Error bars	20263
SEM	20284
p value < 0.01	20293
p value	20293
0.01	20301
Fig. 6 .	20308
Fig.	20308
6	20313
Assessment of axon sprouting within the lesion site 3.5 months post-contusion .	20316
Assessment of axon	20316
Assessment	20316
axon	20330
the lesion site 3.5 months post-contusion	20352
the lesion site	20352
3.5 months	20368
A : Longitudinal sections	20395
Longitudinal	20398
anti-GFAP and anti-neurofilament -LRB- NF -RRB- antibodies	20444
Views of ipsilateral -LRB- injured side -RRB- and corresponding contralateral -LRB- non-injured -RRB- sides	20494
Views	20494
ipsilateral -LRB- injured side -RRB- and corresponding contralateral -LRB- non-injured -RRB- sides	20503
ipsilateral -LRB- injured side -RRB-	20503
ipsilateral	20503
injured side	20516
corresponding contralateral -LRB- non-injured -RRB- sides	20534
neuronal fibers	20596
the ventrolateral and ventromedial part of the spinal cord of OEC-grafted rats -LRB- arrows -RRB-	20628
the ventrolateral and ventromedial part	20628
the spinal cord of OEC-grafted rats -LRB- arrows -RRB-	20671
the spinal cord	20671
OEC-grafted rats -LRB- arrows -RRB-	20690
OEC-grafted rats	20690
arrows	20708
MEDIUM animals	20727
B	20743
Longitudinal sections	20746
anti-5-HT antibody	20792
High numbers of 5-HTpositive axons with varicosities -LRB- arrowheads -RRB-	20812
High numbers	20812
5-HTpositive axons with varicosities -LRB- arrowheads -RRB-	20828
5-HTpositive axons	20828
varicosities -LRB- arrowheads -RRB-	20852
varicosities	20852
arrowheads	20866
the OEC group	20892
the MEDIUM group	20924
Scale bar : 100 μm .	20942
Scale bar	20942
100 μm	20953
C : The area of cystic cavity formed after injury is significantly reduced after OEC transplantation -LRB- n = 4 ; * : p valueb0 .05 -RRB- .	20961
C	20961
The area of cystic cavity formed after injury is significantly reduced after OEC transplantation -LRB- n = 4 ; * : p valueb0 .05 -RRB-	20964
The area	20964
cystic cavity formed after injury is significantly reduced after OEC transplantation -LRB- n = 4 ; * : p valueb0 .05 -RRB-	20976
cystic cavity	20976
injury	21003
OEC transplantation -LRB- n = 4 ; * : p valueb0 .05 -RRB-	21041
OEC transplantation	21041
n = 4 ; * : p valueb0 .05	21062
n	21062
= 4 ; * : p valueb0 .05	21063
= 4	21063
p valueb0	21070
.05	21079
D and E : Fluorescence densitometries for NF-positive -LRB- D -RRB- and 5-HT-positive -LRB- E -RRB- pixels , within the lesion site ,	21085
D and E	21085
D	21085
E	21091
Fluorescence densitometries for NF-positive -LRB- D -RRB- and 5-HT-positive -LRB- E -RRB- pixels	21094
Fluorescence densitometries	21094
NF-positive -LRB- D -RRB- and 5-HT-positive -LRB- E -RRB- pixels	21126
D	21139
E	21161
the lesion site	21179
greater NF and 5-HT immunoreactivity after OEC transplantation -LRB- n = 4 ; ** : p value < 0.01 -RRB-	21217
greater NF and 5-HT immunoreactivity	21217
OEC transplantation	21260
n = 4 ; ** : p value < 0.01	21281
n = 4 ; ** : p value <	21281
n = 4 ; ** : p value	21281
n = 4	21281
n	21281
4	21283
p value	21290
<	21297
0.01	21298
Data	21305
mean ± SEM	21327
the respiratory bulbo-spinal descending pathways that control the phrenic motoneuron discharges	21357
the respiratory bulbo-spinal descending pathways	21357
the phrenic motoneuron discharges	21419
all rats	21454
a lateral contusion	21472
the left side of the spinal cord	21495
the left side	21495
the spinal cord	21512
the C2 cervical level	21531
The efficiency of the contusion	21554
The efficiency	21554
the contusion	21572
control rats -LRB- Fig. 1 -RRB-	21614
control rats	21614
Fig. 1	21628
Immunoreactivity of GAP-43	21637
Immunoreactivity	21637
GAP-43	21657
48 h after injury , nerve fibers of the spinal cord	21679
48 h	21679
injury , nerve fibers of the spinal cord	21690
injury	21690
nerve fibers of the spinal cord	21698
nerve fibers	21698
the spinal cord	21714
the ipsilateral side -LRB- injured side -RRB-	21746
the ipsilateral side	21746
injured side	21768
the controlateral side -LRB- noninjured -RRB-	21788
the controlateral side	21788
a constituent of astrocytes	21844
a constituent	21844
astrocytes	21861
GFAP immunoreactivity	21873
non-injured side of the cord	21911
non-injured side	21911
the cord	21931
GFAP immunoreactivity	21945
the injured side indicating the presence of classical astrocyte reactivity after injury	21986
the injured side	21986
the presence of classical astrocyte reactivity	22014
the presence	22014
classical astrocyte reactivity	22030
injury	22067
Fifteen days	22075
injury	22094
nasal OEC cells	22102
the injured side	22139
one animal group	22159
OEC , n = 6	22187
OEC	22187
n = 6	22192
n	22192
6	22194
the other group	22203
volume-matched DMEM injection -LRB- stated as MEDIUM , n = 6 -RRB-	22228
volume-matched DMEM injection	22228
MEDIUM , n = 6	22269
MEDIUM	22269
n = 6	22277
n	22277
6	22279
We	22283
the animals	22300
3 months	22312
Functional partial recovery of breath behavior	22343
Functional partial recovery	22343
breath behavior	22374
weight-dependent variations	22399
breathing patterns -LRB- Fuller et al. , 2008 -RRB- , Control -LRB- uninjured -RRB-	22430
breathing patterns -LRB- Fuller et al. , 2008 -RRB-	22430
breathing patterns	22430
Fuller	22450
et al. , 2008	22457
et al.	22457
2008	22465
Control -LRB- uninjured -RRB-	22472
Control	22472
MEDIUM and OEC rat groups	22493
Control : 0.302 ± 0.011 ; MEDIUM : 0.312 ± 0.013 ; OEC : 0.325 ± 0.028 kg	22540
Control	22540
0.302 ± 0.011 ; MEDIUM : 0.312 ± 0.013 ; OEC : 0.325 ± 0.028 kg	22549
0.302 ± 0.011	22549
0.302	22549
0.011	22555
MEDIUM : 0.312 ± 0.013	22561
MEDIUM	22561
0.312 ± 0.013	22569
0.312	22569
0.013	22575
OEC : 0.325 ± 0.028 kg	22582
OEC	22582
0.325 ± 0.028 kg	22587
0.325	22587
0.028 kg	22593
Three and half months post-injury , plethysmography analyses	22604
Three	22604
half months post-injury , plethysmography analyses	22614
half months	22614
post-injury , plethysmography analyses	22626
normoxia -LRB- i.e. 21 % O2 , balance N2 -RRB-	22682
normoxia	22682
i.e. 21 % O2 , balance N2	22692
i.e.	22692
21 % O2 , balance N2	22697
21 %	22697
O2 , balance N2	22701
O2	22701
balance N2	22705
injured animals -LRB- either MEDIUM or OEC -RRB-	22718
injured animals	22718
MEDIUM or OEC	22742
lower minute ventilation values compared to control rats	22761
lower minute ventilation values	22761
rats	22813
both MEDIUM and OEC groups	22829
similar minute ventilation values -LRB- Fig. 2A -RRB-	22860
similar minute ventilation values	22860
Fig. 2A	22895
contrast	22908
hypoxia -LRB- 10 % O2 , balance N2 -RRB-	22925
hypoxia	22925
10 %	22934
O2 , balance N2	22938
O2	22938
balance N2	22942
breathing values in OEC-transplanted rats	22955
breathing values	22955
OEC-transplanted rats	22975
MEDIUM -LRB- Fig. 2A -RRB-	23032
MEDIUM	23032
Fig. 2A	23040
respiratory volume parameters	23075
this breath behavior benefit	23130
we	23160
the frequency and tidal volume breathing of the twogroups -LRB- Fig. 2B and C -RRB-	23172
the frequency and tidal volume breathing	23172
the twogroups -LRB- Fig. 2B and C -RRB-	23216
the twogroups	23216
Fig. 2B and C	23231
Fig. 2B	23231
C	23243
normoxia condition	23250
both groups	23270
similar breathing frequency and tidal volume	23286
similar breathing frequency	23286
tidal volume	23318
contrast	23335
OECtransplanted rats	23345
hypoxia	23379
an increase in tidal volume	23392
an increase	23392
tidal volume	23407
breathing frequency	23426
Nasal olfactory ensheathing cells transplantation	23462
Nasal olfactory ensheathing cells	23462
transplantation	23496
diaphragm partial recovery The observed improvement of breathing behavior after OEC transplantation led us to evaluate the spontaneous muscular activity of the diaphragm , 3 months post-transplantation -LRB- Fig. 3 -RRB-	23521
diaphragm partial recovery	23521
The observed improvement of breathing behavior after OEC transplantation	23548
The observed improvement	23548
breathing behavior after OEC transplantation	23576
breathing behavior	23576
OEC transplantation	23601
us	23625
the spontaneous muscular activity of the diaphragm , 3 months post-transplantation -LRB- Fig. 3 -RRB-	23640
the spontaneous muscular activity	23640
the diaphragm , 3 months post-transplantation -LRB- Fig. 3 -RRB-	23677
the diaphragm	23677
3 months post-transplantation -LRB- Fig. 3 -RRB-	23692
3 months post-transplantation	23692
Fig. 3	23723
The frequency of the EMG cycles recorded bilaterally	23732
The frequency	23732
the EMG cycles recorded bilaterally	23749
the EMG	23749
cycles	23757
the same in both groups of animals	23789
the same	23789
both groups of animals	23801
both groups	23801
animals	23816
These findings	23825
those reported above , using plethysmography	23861
those	23861
plethysmography	23889
the right-hemi-diaphragm -LRB- non-injured side -RRB-	23921
the right-hemi-diaphragm	23921
non-injured side	23947
no difference between MEDIUM and OEC groups	23997
no difference	23997
MEDIUM and OEC groups	24019
the left hemi-diaphragm -LRB- injured side -RRB- of the MEDIUM group	24042
the left hemi-diaphragm -LRB- injured side -RRB-	24042
the left hemi-diaphragm	24042
injured side	24067
the MEDIUM group	24084
a weaker activity	24105
that of theOEC groups -LRB- Fig. 3A -RRB-	24141
that	24141
theOEC groups -LRB- Fig. 3A -RRB-	24149
theOEC groups	24149
Fig. 3A	24164
We	24173
21 ± 7 % of the injured hemi-diaphragmremained	24190
21 ± 7 %	24190
21 ±	24190
the injured hemi-diaphragmremained	24199
the right hemi-diaphragmofMEDIUMgroup	24267
theOEC group	24317
activity of the injured hemi-diaphragm	24331
activity	24331
the injured hemi-diaphragm	24343
51 ± 6 % -LRB- Fig. 3B -RRB-	24401
51 ± 6 %	24401
51 ±	24401
Fig. 3B	24408
This significant increased in OEC compared toMEDIUMgroup , in normoxic condition -LRB- p value = 0.025 -RRB- ,	24418
This significant increased in OEC compared toMEDIUMgroup	24418
This significant	24418
OEC	24448
toMEDIUMgroup	24461
normoxic condition -LRB- p value = 0.025 -RRB-	24479
normoxic condition	24479
p value	24499
0.025	24509
hypercapnia conditions -LRB- OEC : 73 ± 7 % ; MEDIUM : 36 ± 11 % ; p value = 0.0286 -RRB-	24542
hypercapnia conditions	24542
OEC : 73 ± 7 % ; MEDIUM : 36 ± 11 % ; p value = 0.0286	24566
OEC	24566
73 ± 7 % ; MEDIUM : 36 ± 11 % ; p value = 0.0286	24571
73 ± 7 %	24571
73 ±	24571
MEDIUM : 36 ± 11 %	24578
MEDIUM	24578
36 ± 11 %	24586
36	24586
11 %	24589
p value = 0.0286	24594
p value	24594
0.0286	24604
a result	24616
the OEC-related improved breathing function	24626
froma recovery of the left hemi-diaphragm , ipsilateral	24681
froma recovery	24681
the left hemi-diaphragm , ipsilateral	24699
the left hemi-diaphragm	24699
ipsilateral	24724
the injured cervical cord	24739
Transplantation of nasal olfactory ensheathing cells	24766
Transplantation	24766
nasal olfactory ensheathing cells	24785
partial recovery of the left phrenic nerve activities	24828
partial recovery	24828
the left phrenic nerve activities	24848
the effects of nasal OEC transplantation in SCI rats	24900
the effects	24900
nasal OEC transplantation in SCI rats	24915
nasal OEC transplantation	24915
SCI rats	24944
we	24954
the spontaneous electrophysiological activities of both the left -LRB- injured -RRB- and right -LRB- uninjured -RRB- phrenic nerves -LRB- Fig. 4A -RRB-	24966
the spontaneous electrophysiological activities of both the left -LRB- injured -RRB-	24966
the spontaneous electrophysiological activities	24966
both the left -LRB- injured -RRB-	25017
both the left	25017
injured	25032
right -LRB- uninjured -RRB- phrenic nerves -LRB- Fig. 4A -RRB-	25045
right -LRB- uninjured -RRB-	25045
right	25045
phrenic nerves -LRB- Fig. 4A -RRB-	25063
phrenic nerves	25063
Fig. 4A	25079
both MEDIUM and OECs rat groups	25092
spontaneous activities of the left and right nerves	25125
spontaneous activities	25125
the left and right nerves	25151
The right phrenic nerve activities of both groups	25191
The right phrenic nerve activities	25191
both groups	25229
no difference between the averaged surfaces of the phrenic nerve integrated traces were detected	25264
no difference	25264
the averaged surfaces of the phrenic nerve integrated traces were detected	25286
the averaged surfaces	25286
the phrenic nerve integrated traces were detected	25311
the phrenic nerve	25311
integrated traces	25329
a consequence of the left lateral contusion	25374
a consequence	25374
the left lateral contusion	25391
the left phrenic nerve activities	25419
the right ones	25477
We	25493
the MEDIUM rats	25511
the left phrenic nerve	25528
an activity average	25561
23 ±	25584
4 %	25587
the right one	25605
the OEC group	25623
the activity	25638
54	25659
± 3 %	25661
the increase in the OEC rats	25672
the increase	25672
the OEC rats	25688
that in the MEDIUM group -LRB- Fig. 4B -RRB-	25732
that	25732
the MEDIUM group -LRB- Fig. 4B -RRB-	25740
the MEDIUM group	25740
Fig. 4B	25758
These results	25768
the functional partial recovery of the diaphragm following the OEC transplantation	25790
the functional partial recovery	25790
the diaphragm following the OEC transplantation	25825
the diaphragm	25825
the OEC transplantation	25849
We	25874
the spinal origin of the left phrenic nerve activity -LRB- Fig. 4C -RRB-	25895
the spinal origin	25895
the left phrenic nerve activity -LRB- Fig. 4C -RRB-	25916
the left phrenic nerve activity	25916
Fig. 4C	25949
lateral left contusion	25965
the left phrenic nerve activity observed in Fig. 4A	25989
the left phrenic nerve activity	25989
Fig. 4A	26033
the contralateral -LRB- uninjured -RRB- spinal cord	26058
the compensatory `` Crossed Phrenic nerve Phenomenon '' -LRB- CPP -RRB- -LRB- Goshgarian , 2003 -RRB- and/or from ipsilateral -LRB- injured -RRB- spinal cord due to a recovery of the ipsilateral descending respiratory pathways	26107
the compensatory	26107
Phrenic nerve Phenomenon ''	26133
-LRB- CPP -RRB- -LRB- Goshgarian , 2003 -RRB-	26159
-LRB- CPP -RRB-	26159
Goshgarian	26166
2003	26178
from ipsilateral -LRB- injured -RRB- spinal cord	26191
injured	26209
a recovery of the ipsilateral descending respiratory pathways	26237
a recovery	26237
the ipsilateral descending respiratory pathways	26251
the ipsilateral	26251
respiratory pathways	26278
these two hypotheses	26311
we	26333
supralesional spinal cord stimulation at the C1 cervical level	26346
supralesional spinal cord stimulation	26346
the C1 cervical level	26387
both MEDIUM and OEC rats	26413
typical orthodromic right phrenic responses	26439
the ventrolateral column of the right C1 cervical spinal cord -LRB- Fig. 4C , right panels -RRB-	26512
the ventrolateral column	26512
the right C1 cervical spinal cord -LRB- Fig. 4C , right panels -RRB-	26540
the right C1 cervical spinal cord	26540
the right C1	26540
cervical spinal cord	26553
Fig. 4C , right panels	26575
Fig. 4C	26575
right panels	26584
No statistical differences	26599
the latency and the amplitude of these responses between two groups	26655
the latency	26655
the amplitude of these responses between two groups	26671
the amplitude	26671
these responses between two groups	26688
these responses	26688
two groups	26712
the stimulation	26738
the ventrolateral column of the left C1 cervical spinal cord	26769
the ventrolateral column	26769
the left C1 cervical spinal cord	26797
the left C1	26797
cervical spinal cord	26809
we	26831
a lack of response of the left phrenic nerve in the MEDIUM group -LRB- Fig. 4C ,	26843
a lack	26843
response of the left phrenic nerve in the MEDIUM group -LRB- Fig. 4C ,	26853
response	26853
the left phrenic nerve in the MEDIUM group -LRB- Fig. 4C ,	26865
the left phrenic nerve in the MEDIUM group	26865
the left phrenic nerve	26865
the MEDIUM group	26891
Fig. 4C	26909
panel	26923
Stimulation	26931
other left C1 spinal cord areas -LRB- lateral , latero-dorsal and ventral columns -RRB- also did not elicit response on the left phrenic nerve -LRB- not illustrated -RRB-	26955
other left C1	26955
spinal cord areas -LRB- lateral , latero-dorsal and ventral columns -RRB-	26969
spinal cord areas	26969
lateral , latero-dorsal and ventral columns	26988
lateral	26988
latero-dorsal and ventral columns	26997
response	27052
the left phrenic nerve	27064
This result	27106
the MEDIUM group	27140
spontaneous activities of the left phrenic nerve , and thus the left hemi-diaphragm	27158
spontaneous activities	27158
the left phrenic nerve , and thus the left hemi-diaphragm	27184
the left phrenic nerve	27184
the left hemi-diaphragm	27217
a recovery of the ipsilateral descending pathways	27263
a recovery	27263
the ipsilateral descending pathways	27277
it	27331
CPP	27345
contrast	27353
the OEC group	27366
stimulation of the ventrolateral column of the left C1 cervical spinal cord	27381
stimulation	27381
the ventrolateral column of the left C1 cervical spinal cord	27396
the ventrolateral column	27396
the left C1 cervical spinal cord	27424
the left C1	27424
cervical spinal cord	27436
orthodromic left phrenic responses with an increased latency and lower amplitude than that obtained on the controlateral right side -LRB- Fig. 4C , left panel -RRB-	27466
orthodromic left phrenic responses	27466
an increased latency and lower amplitude than that obtained on the controlateral right side -LRB- Fig. 4C , left panel -RRB-	27506
an increased latency	27506
lower amplitude than that obtained on the controlateral right side -LRB- Fig. 4C , left panel -RRB-	27531
lower amplitude than that obtained on the controlateral right side	27531
lower amplitude	27531
that obtained on the controlateral right side	27552
that	27552
the controlateral right side	27569
Fig. 4C , left panel	27599
Fig. 4C	27599
panel	27613
Partial recovery of the left phrenic nerve promoted by nasal olfactory ensheathing cells	27621
Partial recovery	27621
the left phrenic nerve promoted by nasal olfactory ensheathing cells	27641
the left phrenic nerve	27641
nasal olfactory ensheathing cells	27676
restoration of ipsilateral supraspinal command	27725
restoration	27725
ipsilateral supraspinal command	27740
the origin of the left phrenic nerve activity that was observed at 3.5 months after ipsilateral trauma	27803
the origin	27803
the left phrenic nerve activity that was observed at 3.5 months after ipsilateral trauma	27817
the left phrenic nerve activity	27817
3.5 months	27870
ipsilateral trauma	27887
we	27907
anesthesia and artificial ventilation conditions	27927
an acute section at the C1 cervical level -LRB- Fig. 5 -RRB-	27977
an acute section	27977
the C1 cervical level -LRB- Fig. 5 -RRB-	27997
the C1 cervical level	27997
Fig. 5	28020
each case	28032
the section	28043
the midline	28068
the right lateral part of the cord along its entire depth	28083
the right lateral part	28083
the cord along its entire depth	28109
the cord	28109
its entire depth	28124
the effect of the progressive section on the activity of both phrenic nerves	28145
the effect	28145
the progressive section on the activity of both phrenic nerves	28159
the progressive section	28159
the activity of both phrenic nerves	28186
the activity	28186
both phrenic nerves	28202
the OEC group	28252
the section	28267
the midline	28301
the left lateral part	28316
We	28339
MEDIUM rats , -LRB- Fig. 5A -RRB-	28356
MEDIUM rats	28356
Fig. 5A	28370
a medial right section	28380
the left phrenic activity	28436
a strong decrease of the right phrenic discharge -LRB- Fig. 5A , trace 2 -RRB-	28476
a strong decrease	28476
the right phrenic discharge -LRB- Fig. 5A , trace 2 -RRB-	28497
the right phrenic discharge	28497
Fig. 5A	28526
trace 2	28535
The right activity	28545
the section	28596
complete C1 right hemisection	28633
Fig. 5A	28665
trace 3	28674
The fact that any left phrenic activity subsisted after right C1 hemisection -LRB- which interrupts descending right command and particularly the pathways potentially involved in the CPP -RRB-	28684
The fact that any left phrenic activity subsisted after right C1 hemisection	28684
The fact	28684
any left phrenic activity	28698
right C1 hemisection	28740
descending right command and particularly the pathways potentially involved	28779
descending right command	28779
particularly the pathways potentially involved	28808
particularly the pathways	28808
the CPP	28858
the left phrenic activity of the MEDIUM rats	28882
the left phrenic activity	28882
the MEDIUM rats	28911
the compensatory effect of the CPP	28943
the compensatory effect	28943
the CPP	28970
contrast for OEC rats	28982
contrast	28982
OEC rats	28995
the medial right section	29005
only poor effect on the left phrenic nerve activity -LRB- Fig. 5B , trace 2 -RRB-	29034
only poor effect	29034
the left phrenic nerve activity -LRB- Fig. 5B , trace 2 -RRB-	29054
the left phrenic nerve activity	29054
Fig. 5B	29087
trace 2	29096
This activity	29106
C1 right hemisection -LRB- Fig. 5B , trace 3 -RRB-	29155
C1 right hemisection	29155
Fig. 5B	29177
trace 3	29186
around half of the activity	29199
around half	29199
the activity	29214
53 % ; Fig. 5C	29238
53 %	29238
Fig. 5C	29243
MEDIUM rats	29261
the right phrenic nerve activity	29274
the rostral ipsilateral hemisection -LRB- Fig. 5B , trace 2 -RRB-	29339
the rostral ipsilateral hemisection	29339
Fig. 5B	29376
trace 2	29385
Total interruption of the left phrenic nerve activity in OEC rats	29395
Total interruption	29395
the left phrenic nerve activity in OEC rats	29417
the left phrenic nerve activity	29417
OEC rats	29452
a complete C1 acute section -LRB- when the section was directed toward the left side -RRB- -LRB- Fig. 5B , trace 4 -RRB-	29492
a complete C1 acute section -LRB- when the section was directed toward the left side -RRB-	29492
a complete C1 acute section	29492
the section	29526
the left side	29558
Fig. 5B	29574
trace 4	29583
Transplantation of nasal olfactory ensheathing cells	29593
Transplantation	29593
nasal olfactory ensheathing cells	29612
the lesion site We finally investigated , at the anatomical level , how OEC transplantation partially restored the ipsilateral command	29677
the lesion site	29677
We	29693
the anatomical level	29721
OEC transplantation	29747
the ipsilateral command	29786
that purpose	29815
we	29829
longitudinal sections	29842
the contusion site	29875
the presence of axons	29907
the presence	29907
axons	29923
the GFAP-positive border	29936
the boundaries of the contusion site	29974
the boundaries	29974
the contusion site	29992
Densitometry of neurofilament -LRB- NF -RRB- and 5-HT axon fibers	30012
Densitometry	30012
neurofilament -LRB- NF -RRB- and 5-HT axon fibers	30028
neurofilament -LRB- NF -RRB-	30028
neurofilament	30028
NF	30043
5-HT axon fibers	30051
NF and 5-HT pixels	30094
the area of the contusion site -LRB- Fig. 6 -RRB-	30120
the area	30120
the contusion site -LRB- Fig. 6 -RRB-	30132
the contusion site	30132
Fig. 6	30152
the MEDIUM group	30164
the rostral , epicenter and caudal sites of the contusion	30182
the rostral , epicenter and caudal sites	30182
the contusion	30225
axons -LRB- Fig. 6A -RRB-	30261
axons	30261
Fig. 6A	30268
48 h	30290
the contusion -LRB- Fig. 1 -RRB-	30301
the contusion	30301
Fig. 1	30316
The small number of bouton-like varicosities of 5-HT immunoreactive fibers	30325
The small number	30325
bouton-like varicosities of 5-HT immunoreactive fibers	30345
bouton-like varicosities	30345
5-HT immunoreactive fibers	30373
the epicenter of the contusion site -LRB- Fig. 6B -RRB-	30427
the epicenter	30427
the contusion site -LRB- Fig. 6B -RRB-	30444
the contusion site	30444
Fig. 6B	30464
other groups -LRB- Ramer et al. , 2004 ; Richter et al. , 2005 -RRB-	30500
other groups	30500
Ramer	30514
et al. , 2004 ; Richter et al. , 2005	30520
et al.	30520
2004 ; Richter et al.	30528
2004	30528
Richter et al.	30534
Richter	30534
et al.	30542
2005	30550
we	30557
3.5 months post-injury , OEC transplantation	30571
3.5 months post-injury	30571
OEC transplantation	30595
cystic cavity area -LRB- Fig. 6C -RRB-	30623
cystic cavity area	30623
Fig. 6C	30643
This reduction of cavity area reduction	30653
This reduction	30653
cavity area reduction	30671
a significant increase in NF-positive and 5-HT axons of currently unknown sources that were promoted by OECs when compared to MEDIUM rats -LRB- Fig. 6D and E -RRB-	30709
a significant increase	30709
NF-positive and 5-HT axons of currently unknown sources that were promoted by OECs when compared to MEDIUM rats -LRB- Fig. 6D and E -RRB-	30735
NF-positive and 5-HT axons	30735
currently unknown sources that were promoted by OECs when compared to MEDIUM rats -LRB- Fig. 6D and E -RRB-	30765
currently unknown sources	30765
OECs when	30813
OECs	30813
MEDIUM rats	30835
Fig. 6D and E	30848
Fig. 6D	30848
E	30860
Neurofilament-positive fibers	30864
a rostro-caudal way	30920
the ventrolateral and ventromedial aspects	30949
the ventrolateral	30949
ventromedial aspects	30971
unaffected ventrolateral neuronal fibers	31006
the white matter of the contralateral side	31064
the white matter	31064
the contralateral side	31084
Bouton-like varicosities of 5-HT immunoreactive fibers	31108
Bouton-like varicosities	31108
5-HT immunoreactive fibers	31136
the contusion site	31187
no evidence of 5-HTpositive cell bodies	31216
no evidence	31216
5-HTpositive cell bodies	31231
both neurofilament and 5 - HT-positive axons	31279
both neurofilament and 5	31279
HT-positive axons	31305
large number rostral to and within the lesion site	31337
large number rostral	31337
the lesion site	31372
small number in the caudal area	31395
small number	31395
the caudal area	31411
Discussion	31429
line with the pioneering studies of Ramón-Cueto and Nieto - Sampedro -LRB- Ramon-Cueto and Nieto-Sampedro , 1994 ; Ramon-Cueto et al. , 1998 -RRB-	31443
line	31443
the pioneering studies of Ramón-Cueto and Nieto - Sampedro -LRB- Ramon-Cueto and Nieto-Sampedro , 1994 ; Ramon-Cueto et al. , 1998 -RRB-	31453
the pioneering studies	31453
Ramón-Cueto and Nieto - Sampedro -LRB- Ramon-Cueto and Nieto-Sampedro , 1994 ; Ramon-Cueto et al. , 1998 -RRB-	31479
Ramón-Cueto and Nieto	31479
Sampedro	31502
Ramon-Cueto and Nieto-Sampedro , 1994 ; Ramon-Cueto et al. , 1998	31512
Ramon-Cueto and Nieto-Sampedro	31512
1994 ; Ramon-Cueto et al.	31544
1994	31544
Ramon-Cueto et al.	31550
Ramon-Cueto	31550
et al.	31562
1998	31570
numerous reports	31577
the therapeutic benefit of OECs	31612
the therapeutic benefit	31612
OECs	31639
rodent models of spinal cord injury -LRB- Richter and Roskams , 2008 -RRB-	31665
rodent models	31665
spinal cord injury -LRB- Richter and Roskams , 2008 -RRB-	31682
spinal cord injury	31682
Richter and Roskams	31702
2008	31723
most of these models , based on straight hemi - or total transection of the thoracic dorsal columns ,	31739
most	31739
these models , based on straight hemi - or total transection of the thoracic dorsal columns ,	31747
these models	31747
straight hemi - or total transection of the thoracic dorsal columns ,	31770
straight hemi	31770
total transection of the thoracic dorsal columns	31788
total transection	31788
the thoracic dorsal columns	31809
the type of injury -- contusion or elongation -- usually observed in humans -LRB- Bohlman and Anderson , 1992 -RRB-	31864
the type	31864
injury -- contusion or elongation -- usually observed in humans -LRB- Bohlman and Anderson , 1992 -RRB-	31876
injury	31876
contusion or elongation	31885
contusion	31885
elongation	31898
humans -LRB- Bohlman and Anderson , 1992 -RRB-	31931
humans	31931
Bohlman and Anderson	31939
1992	31961
the vast majority of studies	31981
the vast majority	31981
studies	32002
a thoracic section	32018
their preferred model	32040
epidemiology	32068
more than 50 % of SCIs in humans	32096
more than 50 %	32096
SCIs in humans	32113
SCIs	32113
humans	32121
a cervical trauma -LRB- Jackson et al. , 2004 -RRB-	32141
a cervical trauma	32141
Jackson	32160
et al. , 2004	32168
et al.	32168
2004	32176
most studies	32192
OECs	32239
the possibility to perform autologous graftings	32266
autologous graftings	32293
the team that conducted the first clinical trial based on the use of nasal OECs	32330
the team	32330
the first clinical trial	32354
the use of nasal OECs	32388
the use	32388
nasal OECs	32399
autologous transplants	32421
chronically injured paraplegic patients -LRB- Feron et al. , 2005 -RRB-	32447
chronically injured paraplegic patients	32447
Feron	32488
et al. , 2005	32494
et al.	32494
2005	32502
Three years	32509
the procedure	32540
feasible and safe -LRB- Mackay-Sim et al. , 2008 -RRB-	32571
feasible and safe	32571
Mackay-Sim	32590
et al. , 2008	32601
et al.	32601
2008	32609
The present study	32616
the first to assess the respiratory benefit of nasal OECs , when subchronically grafted in a rat model of cervical contusion	32637
the respiratory benefit of nasal OECs , when subchronically grafted in a rat model of cervical contusion	32657
the respiratory benefit	32657
nasal OECs , when subchronically grafted in a rat model of cervical contusion	32684
nasal OECs	32684
a rat model of cervical contusion	32727
a rat model	32727
cervical contusion	32742
harmony with the protocol used in the reported clinical trial	32778
harmony	32778
the protocol used in the reported clinical trial	32791
the protocol	32791
the reported clinical trial	32812
we	32841
semi-autologous -LRB- same litter-mate -RRB- graft of nasal OECs	32861
semi-autologous -LRB- same litter-mate -RRB- graft	32861
same litter-mate	32878
nasal OECs	32905
a subchronic model of SCI	32919
a subchronic model	32919
SCI	32941
addition	32949
clinical context	32998
we	33016
a cervical contusion	33027
a persistent unilateral diaphragmatic paralysis -LRB- Baussart et al. , 2006 -RRB-	33057
a persistent unilateral diaphragmatic paralysis	33057
Baussart	33106
et al. , 2006	33115
et al.	33115
2006	33123
we	33139
OECs	33155
a 2-week delay when a peak in reactive astrocyte response is observed -LRB- Tian et al. , 2007 -RRB-	33166
a 2-week delay	33166
a peak in reactive astrocyte response	33186
a peak	33186
reactive astrocyte response	33196
Tian	33237
et al. , 2007	33242
et al.	33242
2007	33250
we	33268
OECs efficiency	33291
glial scarring	33314
a result	33333
this study	33343
the first to assess the respiratory benefit of nasal OECs , when subchronically grafted in a rat model of cervical contusion	33357
the respiratory benefit of nasal OECs , when subchronically grafted in a rat model of cervical contusion	33377
the respiratory benefit	33377
nasal OECs , when subchronically grafted in a rat model of cervical contusion	33404
nasal OECs	33404
a rat model of cervical contusion	33447
a rat model	33447
cervical contusion	33462
We	33482
there	33496
a significant difference in the response	33506
a significant difference	33506
the response	33534
hypoxia between the MEDIUM and OEC groups	33550
hypoxia	33550
the MEDIUM and OEC groups	33566
the hypoxia-induced increase in minute ventilation	33593
the hypoxia-induced increase	33593
minute ventilation	33625
the OEC than MEDIUM rats	33659
the OEC	33659
MEDIUM rats	33672
Similar minute ventilation during normoxia in both groups of rats	33685
Similar minute ventilation	33685
normoxia in both groups of rats	33719
normoxia	33719
both groups of rats	33731
both groups	33731
rats	33746
an agreement with -LRB- Fuller et al. , 2008 -RRB- who reported that cervical hemisection does not impair basic levels of ventilation despite of persisting chronic injury	33757
an agreement with -LRB- Fuller et al. , 2008 -RRB-	33757
an agreement	33757
Fuller	33776
et al. , 2008	33783
et al.	33783
2008	33791
cervical hemisection	33815
basic levels of ventilation	33852
basic levels	33852
ventilation	33868
chronic injury	33902
the capacity of an injured rat to maintain basic levels of ventilation and to respond to increased respiratory drive	33927
the capacity	33927
an injured rat to maintain basic levels of ventilation and to respond to increased respiratory drive	33943
basic levels of ventilation	33970
basic levels	33970
ventilation	33986
increased respiratory drive	34016
the CPP -LRB- Fuller et al. , 2008 ; Golder et al. , 2003 -RRB-	34068
the CPP	34068
Fuller	34077
et al. , 2008 ; Golder et al. , 2003	34084
et al.	34084
2008 ; Golder et al.	34092
2008	34092
Golder et al.	34098
Golder	34098
et al.	34105
2003	34113
we	34126
3.5 months post-injury , basic levels of ventilation in injured rats -LRB- MEDIUM group -RRB-	34143
3.5 months post-injury	34143
basic levels of ventilation in injured rats -LRB- MEDIUM group -RRB-	34167
basic levels	34167
ventilation in injured rats -LRB- MEDIUM group -RRB-	34183
ventilation	34183
injured rats -LRB- MEDIUM group -RRB-	34198
injured rats	34198
MEDIUM group	34212
the CPP	34246
an acute contralateral hemisection	34257
ipsilateral phrenic rhythmic output	34313
CPP	34350
play	34365
the OEC group	34373
the unique component	34398
the acute contralateral hemisection	34425
the ipsilateral phrenic rhythmic output	34477
the OEC group	34521
persistent spontaneous activities of both the ipsilateral phrenic nerve and the diaphragm and their response to hypercapnia	34536
persistent spontaneous activities of both the ipsilateral phrenic nerve and the diaphragm	34536
persistent spontaneous activities	34536
both the ipsilateral phrenic nerve and the diaphragm	34573
the ipsilateral phrenic nerve	34578
the diaphragm	34612
their response to hypercapnia	34630
their response	34630
hypercapnia	34648
that OECs may restore , at least partially , the injured phrenic input	34669
OECs	34674
the injured phrenic input	34712
Functional electrophysiology findings	34739
a role of OECs in the re-establishment of the ipsilateral injured phrenic central command	34790
a role	34790
OECs in the re-establishment of the ipsilateral injured phrenic central command	34800
OECs	34800
the re-establishment of the ipsilateral injured phrenic central command	34808
the re-establishment	34808
the ipsilateral injured phrenic central command	34832
supralesional stimulation -LRB- at C1 level -RRB-	34888
supralesional stimulation	34888
C1 level	34918
sublesional ipsilateral postsynaptic phrenic responses	34937
the OEC group	34995
the MEDIUM group	35020
the spontaneous ipsilateral phrenic rhythmic activity which was maintained after an acute C1 contralateral hemisection	35046
the spontaneous ipsilateral phrenic rhythmic activity	35046
an acute C1 contralateral hemisection	35127
an acute ipsilateral C1 hemisection	35200
the involvement of ipsilateral pathways	35269
the involvement	35269
ipsilateral pathways	35288
restoration in maintaining phrenic activity after contralateral lesion	35309
restoration	35309
phrenic activity	35336
contralateral lesion	35359
we	35389
the partial recovery seen after OEC transplants	35412
the partial recovery	35412
OEC transplants	35444
a contralateral path that sprouts to the injured side above the level of the acute C1 contralateral hemisection	35477
a contralateral path	35477
the injured side above the level of the acute C1 contralateral hemisection	35514
the injured side	35514
the level of the acute C1 contralateral hemisection	35537
the level	35537
the acute C1 contralateral hemisection	35550
Anatomical data	35590
the observed respiratory recovery	35631
Spinal cord contusion	35666
a dramatic loss of axons	35704
a dramatic loss	35704
axons	35723
the boundaries of the injury site	35743
the boundaries	35743
the injury site	35761
contrast	35781
rostro-caudal transplantation of nasal OECs	35791
rostro-caudal transplantation	35791
nasal OECs	35824
axonal regrowth	35844
This observed axogenesis	35861
This	35861
axogenesis	35875
line with previous studies	35892
line	35892
previous studies	35902
the hypertrophic response of OECs	35930
the hypertrophic response	35930
OECs	35959
axonal regrowth -LRB- Raisman and Li , 2007 -RRB-	35967
axonal regrowth	35967
Raisman and Li , 2007	35984
Raisman	35984
Li , 2007	35996
Li	35996
2007	36000
example	36011
it	36020
OECs	36037
hypertrophic response of host astrocyte -LRB- Santos-Silva et al. , 2007 -RRB- , ii -RRB-	36053
hypertrophic response	36053
host astrocyte -LRB- Santos-Silva et al. , 2007 -RRB- , ii -RRB-	36078
host astrocyte	36078
host	36078
astrocyte	36083
Santos-Silva	36094
et al. , 2007	36107
et al.	36107
2007	36115
ii	36122
the expression of chondroitin sulfate proteoglycans -LRB- CSPG -RRB- in reactive astrocytes -LRB- Lakatos et al. , 2000 -RRB- , iii -RRB-	36133
the expression	36133
chondroitin sulfate proteoglycans -LRB- CSPG -RRB- in reactive astrocytes -LRB- Lakatos et al. , 2000 -RRB- , iii -RRB-	36151
chondroitin sulfate proteoglycans -LRB- CSPG -RRB- in reactive astrocytes	36151
chondroitin sulfate proteoglycans -LRB- CSPG -RRB-	36151
chondroitin sulfate proteoglycans	36151
CSPG	36186
reactive astrocytes	36195
Lakatos	36216
et al. , 2000	36224
et al.	36224
2000	36232
iii	36239
the size of cavities -LRB- Richter et al. , 2005 -RRB-	36250
the size	36250
cavities -LRB- Richter et al. , 2005 -RRB-	36262
cavities	36262
Richter	36272
et al. , 2005	36280
et al.	36280
2005	36288
iv	36295
a tube-like structure	36306
a bridge	36340
lesioned axons -LRB- Li et al. , 2004 ; Sasaki et al. , 2004 -RRB- , and v -RRB-	36353
lesioned axons	36353
Li	36369
et al. , 2004 ; Sasaki et al. , 2004 -RRB- , and v	36372
et al.	36372
2004 ; Sasaki et al. , 2004 -RRB-	36380
2004	36380
Sasaki et al. , 2004 -RRB-	36386
Sasaki	36386
et al.	36393
2004	36401
v	36412
angiogenesis -LRB- Richter et al. , 2005 -RRB-	36423
angiogenesis	36423
Richter	36437
et al. , 2005	36445
et al.	36445
2005	36453
line with these previously published data on the consequences of OECs grafting	36463
line	36463
these previously published data on the consequences of OECs grafting	36473
these previously published data	36473
the consequences	36508
OECs	36528
we	36543
nasal OECs	36562
cystic size cavities which probably could create a bridge	36580
cystic size cavities	36580
a bridge	36629
axonal regrowth	36661
these studies	36690
OECs , from bulbar or nasal origin ,	36721
OECs	36721
bulbar or nasal origin	36732
a positive environment for injured axons	36764
a positive environment	36764
injured axons	36791
the cellular and molecular events	36828
the glial scar	36870
date	36889
there	36895
no a single antigen recognized as an unambiguous marker of this cell type	36904
no a single antigen	36904
an unambiguous marker of this cell type	36938
an unambiguous marker	36938
this cell type	36963
a consequence	36982
it	36997
our cultures	37035
other cell types	37061
We	37079
our culture conditions	37102
we	37126
pure populations -LRB- up to 98 % -RRB- of cells expressing GFAP and S100 -LRB- Bianco et al. , 2004 -RRB-	37146
pure populations	37146
up to 98 %	37164
cells expressing GFAP and S100 -LRB- Bianco et al. , 2004 -RRB-	37178
cells	37178
GFAP and S100 -LRB- Bianco et al. , 2004 -RRB-	37195
GFAP and S100	37195
Bianco	37210
et al. , 2004	37217
et al.	37217
2004	37225
it	37246
some of the stem cells residing in the lamina propria -LRB- Delorme et al. , 2010 -RRB- , which may express these two proteins ,	37273
some	37273
the stem cells residing in the lamina propria -LRB- Delorme et al. , 2010 -RRB-	37281
the stem cells	37281
the lamina propria -LRB- Delorme et al. , 2010 -RRB-	37308
the lamina propria	37308
Delorme	37328
et al. , 2010	37336
et al.	37336
2010	37344
these two proteins	37369
our culture dishes	37405
survival and migration of transplanted cells	37444
survival and migration	37444
transplanted cells	37470
we	37490
them	37517
the gene coding for the fluorescent protein GFP , using a lentivirus	37527
the gene	37527
the fluorescent protein GFP	37547
a lentivirus	37582
our lab with human cells -LRB- Delorme et al. , 2010 -RRB-	37621
our lab	37621
human cells -LRB- Delorme et al. , 2010 -RRB-	37634
human cells	37634
Delorme	37647
et al. , 2010	37655
et al.	37655
2010	37663
half of the rat	37676
half	37676
the rat	37684
cells	37692
1 day in the appropriate culture medium	37735
1 day	37735
the appropriate culture medium	37744
a few days	37785
we	37803
GFP expression	37820
we	37853
high numbers of cells with a stable GFP expression	37870
high numbers	37870
cells with a stable GFP expression	37886
cells	37886
a stable GFP expression	37897
transplantation	37928
We	37945
the lentiviral vector itself was not packaged properly or has not integrated the genome In regard to locomotor recovery after SCI , it is worth mentioning that several studies have reported an increase of 5-HT	37959
the lentiviral vector	37959
itself	37981
the genome In regard to locomotor recovery after SCI , it is worth mentioning that several studies have reported an increase of 5-HT	38036
the genome	38036
locomotor recovery	38060
SCI	38085
it	38090
several studies	38118
an increase of 5-HT	38148
an increase	38148
5-HT	38163
immunoreactive axons following engraftment of OEC or embryonic cells	38168
immunoreactive axons	38168
engraftment of OEC or embryonic cells	38199
engraftment	38199
OEC or embryonic cells	38214
Fouad et al. , 2005 ; Lopez-Vales et al. , 2006 ; Lopez-Vales et al. , 2007 ; Lu et al. , 2001 ; Ramon-Cueto et al. , 1998 ; Richter et al. , 2005	38238
Fouad	38238
et al. , 2005 ; Lopez-Vales et al. , 2006 ; Lopez-Vales et al. , 2007 ; Lu et al. , 2001 ; Ramon-Cueto et al. , 1998 ; Richter et al. , 2005	38244
et al. , 2005	38244
et al.	38244
2005	38252
Lopez-Vales et al. , 2006	38258
Lopez-Vales	38258
et al. , 2006	38270
et al.	38270
2006	38278
Lopez-Vales et al. , 2007	38284
Lopez-Vales	38284
et al. , 2007	38296
et al.	38296
2007	38304
Lu et al. , 2001	38310
Lu	38310
et al. , 2001	38313
et al.	38313
2001	38321
Ramon-Cueto et al. , 1998	38327
Ramon-Cueto	38327
et al. , 1998	38339
et al.	38339
1998	38347
Richter et al. , 2005	38353
Richter	38353
et al. , 2005	38361
et al.	38361
2005	38369
These results	38376
a regeneration of the raphe-spinal pathway	38398
a regeneration	38398
the raphe-spinal pathway	38416
Some studies	38442
5-HT-positive axons and occasionally interneurons	38467
axons	38481
the caudal stump	38533
a spinal cord section -LRB- Kubasak et al. , 2008 ; Newton et al. , 1986 ; Takeoka et al. , 2009 -RRB-	38556
a spinal cord section	38556
Kubasak et al. , 2008 ; Newton et al. , 1986 ; Takeoka et al. , 2009	38579
Kubasak	38579
et al. , 2008 ; Newton et al. , 1986 ; Takeoka et al. , 2009	38587
et al. , 2008	38587
et al.	38587
2008	38595
Newton et al. , 1986	38601
Newton	38601
et al. , 1986	38608
et al.	38608
1986	38616
Takeoka et al. , 2009	38622
Takeoka	38622
et al. , 2009	38630
et al.	38630
2009	38638
our contusion model	38648
we	38669
5-HT cell bodies or immunoreactive axons	38689
5-HT cell bodies	38689
immunoreactive axons	38709
the midline of the spinal cord	38739
the midline	38739
the spinal cord	38754
the OECs rats	38783
immunoreactive axons	38798
a high number of fibers in the rostral stump within the contusion site	38867
a high number	38867
fibers in the rostral stump within the contusion site	38884
fibers	38884
the rostral stump within the contusion site	38894
the rostral stump	38894
the contusion site	38919
These findings	38939
the hypothesis	38962
OECs	38982
the remodeling of propiospinal 5-HT interneurons	39023
the remodeling	39023
propiospinal 5-HT interneurons	39041
central pathway regeneration and/or non-injured descending axons sprouting	39096
central pathway regeneration	39096
non-injured descending axons sprouting	39132
non-injured descending axons	39132
Such a	39172
central descending pathway reorganization could originate from 5HT raphe-spinal neurons which are known to directly innervate phrenic motoneurons and participate in respiratory plasticity during intermittent hypoxia	39179
central descending pathway reorganization	39179
5HT	39242
raphe-spinal neurons which are known to directly innervate phrenic motoneurons and participate in respiratory plasticity during intermittent hypoxia	39246
raphe-spinal neurons	39246
phrenic motoneurons	39305
respiratory plasticity	39344
intermittent hypoxia	39374
Baker-Herman et al. , 2004 ; Dobbins and Feldman , 1994	39396
Baker-Herman	39396
et al. , 2004 ; Dobbins and Feldman , 1994	39409
et al. , 2004	39409
et al.	39409
2004	39417
Dobbins and Feldman , 1994	39423
Dobbins and Feldman	39423
1994	39444
conclusion	39454
the current study	39466
a specific motor function -LRB- respiration -RRB- , new evidence	39498
a specific motor function -LRB- respiration -RRB-	39498
a specific motor function	39498
respiration	39525
new evidence	39539
nasal OEC transplantation	39557
a partial recovery of respiratory function of the diaphragm following an injury of the cervical cord	39594
a partial recovery	39594
respiratory function of the diaphragm following an injury of the cervical cord	39616
respiratory function	39616
the diaphragm following an injury of the cervical cord	39640
the diaphragm	39640
an injury of the cervical cord	39664
an injury	39664
the cervical cord	39677
Our results	39696
clinical implications	39719
a potential treatment of the ventilator-dependent tetraplegic patients	39744
a potential treatment	39744
the ventilator-dependent tetraplegic patients	39769
